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Abstracts 
It was found that the distribution and metabolism of many biologically active compounds 
in the body weather drugs or natural products are correlated with their affinities toward 
serum albumin. Thus; the study of the interaction of such molecules with albumin is of 
imperative and fundamental importance. Extensive studies on different aspects of drug-
HSA interactions are still in progress because of the clinical significance of the processes.  
In this study the interaction of Procaine (local anesthesia) and Dopamine (neurotransmitter 
in the mammalian central nervous system) with human serum albumin have been studied 
using UV-VIS spectrophotometer, fluorescence spectrophotometer, and FT-IR 
spectroscopy.  
The results show that UV-absorption intensity was increased with the increase of procaine 
or Dopamine molar ratios in fixed amount of HSA. From UV spectra the binding constants 
were obtained and equals (1.00115599× 310 M-1 )for Procaine and (0 .849044×10
3 M-1) for 
Dopamine. 
The analysis of Fluorescence spectra indicated that Procaine and Dopamine have ability to 
quench the intrinsic Fluorcence of HSA through contribution of static and dynamic 
quenching procedure. The quenching rate constant values were determined to be
910566.0 × M-1] for Procaine, and  ]10046651[ 19 −×⋅ M
  
for Dopamine . 
The binding constants from Fluorescence spectrum for Procaine-HSA complexes were 
found to be [1.13818×103 M-1], and for Dopamine-HSA complexes were found to be 
[0.88122×103M-1]. It was obviously noted that the obtained values agree well with the 
values obtained using UV-VIS spectrophotometer, and that procaine binding constant is 
larger than Dopamine binding constant, this refer to the structure of the two compounds 
which is consistent with that has been reported. 
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FT-IR spectroscopy with Fourier self-deconvolution and second derivative, as well as peak 
picking were used in the analysis of amide I, amide II, and amide III regions of HSA to 
determine protein secondary structure, Procaine, and Dopamine binding mechanism. It was 
observed that the intensity of absorption bands change after interaction between two drugs 
and HSA protein which indicate that the interaction and binding have taken place. Also all 
peak positions of the three amide regions were assigned at different Procaine or Dopamine 
ratios. 
In addition, FT-IR spectra evidence showed that HSA secondary structure has been 
changed as Procaine or Dopamine molar ratios increased. The variation in the intensity is 
related indirectly to the formation of H-bonding in the complex molecules, which accorded 
for the different intrinsic propensities of α –helix and β –sheets. 
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Chapter one : Introduction 
Local anesthesia is a drug which reversibly prevents the transmission of the nerve impulse 
where it is applied without affecting consciousness. Local anesthesias are divided into 
amide and ester classes as described in figure 1.2 . Historically, amide (lidocaine 
bupivacaine, Marcaine) and ester (procaine, tetracaine, Pontocaine) anesthetics were both 
used, but esters lost their favor after reports of increased sensitization(Covino et al., 
1986).Chemical structure of local anesthesia is described in figure 1.1. 
 
 
 
 
Figure1. 1.:Chemical structure of  Local anesthesia.(Covino et al., 1986) 
 
 
 
Figure1. 2:  Amino acid and Amino acid ester Local anesthesia(Hara et al. , 2007) 
 
Procaine is an ester local anesthetic used alone or with penicillin as an antibacterial drug. 
"Pro" has a chemical name of(2-diethyl aminoethyl-4-aminobenzoate hydrochloride) and 
its formula C 13 H 20 N 2 O 2 with molecular weight of (272.8g/mole). Its chemical structure 
is described in figure (1.3). (Kahl et al., 2004) 
 
Procaine and other local anesthetic drugs prevent the generation from the conduction of the 
nerve impulses. Their main action site is the cell membrane since conduction block can 
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be demonstrated in giant axons from which the exoplasm has been removed.(Hara et al., 
2007; Kahl et al., 2004). 
 
Procaine is used in obstetrics and sometimes for relieving pain in the lower back and tooth 
extraction.(Malamed et al., 2001) ."Pro" shows a short duration of action and adverse side 
effects, such as cardiac and neurological toxicity. Its short action is exerted by its storage 
in proteins and transportation by proteins in blood plasma.(Xie et al., 2015).  
 
 
 
Figure1 .3Figure1. 1: Chemical Structure of Procaine. (Racine et al., 1975; Xie et al., 
2015) 
Dopamine is a major neurotransmitter in the mammalian central nervous 
system. It's involved in the control of the locomotors activity and also in the pathways that 
regulate pleasure and reward-seeking behavior.(Bäckman et al., 2010).Parkinson’s disease 
is a degenerative ailment of the central nervous system. Its symptoms can be treated with 
medication that increases the dopamine level in the brain. Also, in the past few decades, 
there has been a serious debate on the role of dopamine in drug addiction. Now, it is 
generally accepted that this substance is pivotal in the development and persistence of the 
addiction.(Bäckman et al., 2010; Bergin et al.,1968; Q. Zhang et al.,2012)  
In general, dopamine (DA) is related to the overstimulation of emotions, pleasure, and 
reward systems. The repeated experience of which, via drug taking, facilitates the 
development of craving patterns, that is, drug addiction .(Chen et al.,  2003)  
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Dopamine Hydrochloride is chemically designated 3, 4-dihydroxyphenethylamine 
hydrochloride and its formula is (C8H11NO2 • HCl).its chemical structure described in 
figure (1.4). A white crystalline powder freely soluble in water. It has the following 
structural formula(Ungless et al., 2010). 
 
 
Figure1. 4:Chemical Structure of Dopamine.(Young et al., 2011). 
 
Human serum albumin which is denoted by (HSA) is a major and most abundant 
prominent protein found in plasma, it is synthesized in the liver and accounts for at least 
10% of liver protein synthesis. Its physiological and pharmacological properties have been 
extensively studied over several decades.(H. Zhang et al.,  2008). 
HSA is best known for its extraordinary ligand binding capacity. Also, it has a high affinity 
to a very wide range of endogenous and exogenous ligand and materials, including metals 
such as Cu2+ and Zn2+, fatty acids, amino acids, metabolites such as bilirubin and for many 
drug compounds.(Bhattacharya et al., 2000).The most important physiological role of the 
protein is to move such solutes into the bloodstream to their target organ in addition to its 
role in transporting the endogenous and exogenous ligands.(He et al., 2005). 
The drugs distribution, metabolism, and efficacy and the biologically active 
compounds can be altered on the basis of their affinity to serum albumin. Significantly as 
shown in figure (1.5), the determination and understanding of dopamine’s and procaine's 
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interacting with serum albumin is crucial for the therapy and the design of the drug (Young 
et al., 2011).  
The interaction knowledge and its binding to HSA does not only give information on the 
pharmacological action of that drugs and illuminates its binding mechanism, but it also 
provides guidance on whether the role of dopamine and procaine is restricted to the 
reward-addiction state or to any possible alternative explanations especially to the 
inconsistent findings on dopamine and procaine drug addiction.(Zhang et al., 2012). 
 
 
Figure1. 5-: Schematic drawing of the HSA molecule. Each sub domain is marked with a 
different color ( yellow for sub domain Ia; green, Ib ; red, IIa; magenta, IIIb; blue, IIa; and 
cyan, IIIb).(Khan et al., 2008). 
The molecular interactions between HSA and some compounds have been 
investigated successfully.(Stan et al., 2009). (Lupidi et al.,2010) evaluated the interactions 
between TQ and HSA by various spectroscopic techniques. A research carried out 
by Tajmir-Riahi (Tajmir et al ., 2007) studied various drugs binding to high concentrations 
of HSA, and determined the effects of drug complexion on protein secondary confirmation. 
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(Bia et al., 2009) presented a study about the interaction of HSA with phenothiazine drugs 
by using fluorescence quenching and differentiation between static and dynamic 
quenching. (Moosavi et al.,2006)determined the interaction of HSA with bilirubin.   (Sugio 
et al., 1999) studied the effects of acyclovir and triton–X-100 on the behavior of HSA by 
many spectroscopic techniques. 
The interaction of alpinetin with HSA was studied by (He et al.,2005) and by many 
spectroscopy techniques such as Fourier transform infrared spectroscopy, fluorescence 
quenching and U.V. absorption spectroscopy and circular dichroism.  (Li et al., 2011) 
studied the binding between plumbagin to HSA in physiological conditions by 
fluorescence spectroscopy.(Bai et al., 2009)studied the interaction between 
the sinomenine and Bovine Serum Albumin (BSA) by fluorescence spectra, Fourier 
Transform-Infrared and Circular Dichroism spectroscopy. 
(Stan et al., 2009), investigated the binding parameters (binding constants and number of 
binding sites) and quenching constants for the interaction of new indanedione derivatives 
with HSA and Bovine Serum Albumin (BSA) by fluorescence technique. A study 
performed by (Krisko et al., 2005)to investigate the binding of caffeine to HSA based on 
the application of fluorescence spectroscopy. And they estimated the binding constant of 
this interaction. 
(Khan et al., 2008)studied the binding of thiopental with HSA by UV absorption and 
fluorescence spectroscopy. 
In recent years, many investigations on drugs and natural products binding to protein have 
been carried out. Procaine's interaction with HSA was studied  via using a multi-way 
calibration method coupled with three-dimensional fluorescence spectroscopy(Xie et al., 
2015).That investigation reported that procaine binds to HSA. 
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Dopamine's interaction with bovine serum albumin (BSA) was studied by different 
spectroscopic techniques. In addition, a fluorescence quenching mechanism was associated 
with this process. Estimated thermodynamic parameters indicated the presence of 
hydrogen bonding and van der Walls forces between dopamine and BSA. (Q. Zhang et al., 
2012).That investigation reported that DA binds to BSA and since BSA is an album in 
protein such as HSA, I predicted that DA may bind HSA. 
In this thesis, the interaction of procaine and dopamine with HSA will be investigated in 
details by means of three different spectroscopy FT-IR, UV-VIS, and fluorescence 
spectrophotometer to determine in details the Pro-HSA, and DA-HSA binding constants 
and the effects of Pro or DA complexation on the protein structure. 
Infrared spectroscopy provides measurements of molecular vibrations due to the specific 
absorption of infrared radiation by chemical bonds .Its known that the form and frequency 
of the amide I band, which is assigned to C==O stretching vibration within the peptide 
bonds is very characteristic for the structure of the studied protein from the band secondary 
structure, components peaks ),( sheetsixhe −− βα  can be derived and the analysis of this 
single band allows elucidation of conformational changes with high sensitivity (Darwish et 
al.,2010). 
This work will be limited to the mid-range infrared, which covers the frequency range 
from 4000 to 400 1−cm .This wavenumber region includes bands that arise from three 
conformational sensitive vibrations within the peptide backbone [Amide I, II, and III]. 
Amide I is the most widely used and can provide information on secondary structure 
composition and structural  stability .However , it has been reported that amide II and 
amide III bands have high information content and could be used for prediction of proteins 
secondary structure .(Abu Teir et al., 2012). 
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It has recently been proved that serum albumin plays a decisive role in the transport and 
disposition of a variety of endogenous and exogenous such as fatty acids, hormones, 
drugs(Abu Teir et al., 2011).Another spectroscopic technique is usually used in studying 
drugs interact with proteins, such as fluorescence and UV-VIS spectrophotometer which is 
commonly used due to their high sensitivity, rapidity, and ease of implementation (Saleh et 
al., 2003). 
Beside this chapter, four chapters will be covered in this thesis. Chapter two will discuss 
the theoretical aspects and the important ideas of this study. Chapter three discuss the 
experimental, procedures, and instrumental devices that used in our study. Chapter four 
shows and discussed the results that have been obtained. And the last chapter is about the 
conclusions and future work.        
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Theoretical Background: Theoretical Background 
 
Biophysics is a branch of science which uses and applies physics, Biology, 
chemistry, mathematical equations and computer model. These are used to study, to 
analyze and to explain how the biological system works. We can consider this science as 
the bridge between physics, chemistry, and biology. Biophysics is a molecular science 
which dramatically ranges from small fatty acid and sugars to macromolecules, such 
as protein. 
 
Biophysics seeks for explaining the biological function in terms of molecular structure 
and biological interaction using the spectroscopic techniques of physics and chemistry. The 
relationship between both the biological function and the molecular structure is 
investigated via using highly precise and exquisitely sensitive physical instruments and 
techniques.  
 
Research in Biophysics had been started for first time in India in the late of the nineteenth 
century when the renowned physicist J.C. Bose began his pioneering work on the behavior 
of cells under external stimuli. Nowadays, more than a hundred research groups distributed 
in different institutions around the world are engaged in research in the field of 
Biophysics. Among them, they cover almost all aspects of biophysics, especially at the 
molecular level.  
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The spectrophotometer is one of the instruments and techniques that are used to study the 
biological interaction system and its function such as protein 
this chapter will cover theoretical aspects of this research. The first 
two sections will include and contain the development of this technique whereas the 
second will discuss the electromagnetic spectrum. The next section will briefly cover the 
molecular vibration. The other three sections will discuss the spectroscopic techniques I 
adopted in this work. They are FT-IR, UV-VIS, and Fluorescence one. The 
last chapter includes protein structure and protein mode that I used as a 'Human Serum 
Albumin (HSA)" 
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2.1 Fourier Transform Infrared Spectroscopy (FT-IR) development 
 
Spectroscopy is a study of interaction between matter and electromagnetic radiation. When 
matter absorbs radiation, its molecules excited to higher molecular vibrational state. The 
probability of interaction between matter and electromagnetic radiation depends on the 
interaction between actual frequency and matter. Since each material is unique in its atom 
components, there are no two compounds that can produce the same spectrum.  
Therefore, we can consider spectroscopic technique as a fingerprint and a qualitative 
analysis technique. Also, the size of the peaks can be considered as an indicator to the 
quantity of material where its peaks could be noticed by interaction of radiation with it. In 
the spectroscopic technique, the researcher carried out both the quantitative and the 
qualitative technique as tools of the study.(Sathyanarayana et al., 2015) 
 
Fourier Transform spectroscopy is a general term that describes the analysis of any varying 
signal into its constitute frequencies component. FTS can for many spectroscopes include 
infrared spectroscopy, nuclear magnetic and electron spin resonance spectroscopy (Stuart 
et al., 2004). FTS can be used for a long range of frequencies varying from ultraviolet 
range to far infrared regions. 
 In FT spectroscopy, the samples don’t expose to varying energy of an electromagnetic 
radiation. It is exposed to a signal pulse of radiation consisting of frequency in particular 
range. When the interaction occurs between specific energy radiation and the sample, the 
energy will be absorbed resulting in a series of peaks in the spectrum signal corresponding 
to the frequencies of vibrations between the bonds of the atoms making up the 
material.(Rosén et al., 2010). 
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FTIR spectroscopy is a strong and a powerful analytical spectroscopic technique that is 
used to study and to analyze the biological system structure, interactions, and functions. A 
good example for this is the protein system which studies the spectrum that appears during 
the electromagnetic radiation in the IR region interaction with the biological system. By 
determining what fraction of the incident radiation is absorbed in a particular energy.( 
Stuart et al., 2004). 
The energy spectrum where its absorption reaches its peak corresponds to the frequency of 
the vibration of the molecule sample. Then, we can get much information of 
that system such as band positions, bandwidth, absorption, an investigation 
of protein folding, unfolding and other protein structural changes that occur during 
molecular interactions.( Stuart et al., 2005). 
The Fourier transform science began in the late of the 
1880s when Albert Michelson invented the first interferometer which was known 
as Michelson interferometer. He was able to do his famous experiment and 
to determine the speed of light. The lack of the sensitive detectors, the Fourier 
nonexistence and the algorithm transform were the main barriers. Due to its practical 
applications, in the late of 1940s Fourier came to the scene when scientists 
used interferometer to determine the light from celestial in 1994 the 
first Fourier transform spectrum was produced .(Markovich et al., 1991). 
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At the onset of 1960, the interest of interferometry spectroscopy was gradually increased in 
addition to its applications in physics started to appear. In 1969, the first near-infrared 
planetary spectra were recorded. Later, in 1969 high resolution and high-quality spectra of 
the planets were measured. By 1970, FTS started to be the invaluable tool for 
the researches.(Kast et al., 2015).  
 
The first FT-IR spectrometer was huge, expensive, and difficult to use, and primarily found 
in a well-to-do research laboratory. Today, technology is reducing the cost, increasing the 
availability, and enhancing the capabilities of FT-IR spectrometers. Moreover, developed 
and fast computer are currently added to FTS. This performs Fourier transformation in the 
fraction of a second in the visible, infrared, and microwave regions that are common in 
the laboratory instruments.(Ferrari et al., 2012). 
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2.2 Electromagnetic Radiation 
 
Optical Spectroscopy is an analytical technique used to study the interaction between 
matter and electromagnetic radiation. It is called "optical technique" because it uses an 
optical material to disperse and focus the radiation on the intended matter .(Henderson et 
al., 2006). 
 
The Electromagnetic radiation can be defined as a form of energy that consists of 
oscillating electric and magnetic field which propagate along a linear path. Also, the 
constant velocity of c ( sm /103 8× ) when that radiation moves in a vacuum, 
and velocity of v which is less than c when it moves through a medium.  
 
Electric and magnetic field oscillation is perpendicular to each other and to the direction 
of wave's propagation, Figure (2-1) shows an example of plane-polarized electromagnetic 
radiation, consists of a single oscillating electric field and a single oscillating magnetic 
field.(Stedwell et al., 2013).  
 
 
 
Figure2. 1:Plane-polarized electromagnetic radiation showing the oscillating electric field 
in red and the oscillating magnetic field in blue. The radiation’s amplitude, A, and its 
wavelength, λ, are shown.(Stedwell et al., 2013). 
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The Electromagnetic radiation show proprieties of both wave and particle known as 
the wave-particle duality, in the wave model electromagnetic radiation described by its 
frequency f, wavelength λ, and velocity c. These characteristics are related to each other 
by the equation (1).(Harvey et al., 2000) 
 
λfc = …..…. (1) 
 
Under certain conditions, the electromagnetic radiation shows particle-like nature that is 
called a photon. Thus, it's useful to describe electromagnetic radiation as the packet of 
energy (Harveyet al., 2000; Stedwell et al., 2013). 
Albert Einstein put equation (2) which describes the relationship between photon's energy, 
the frequency, and the wavelength as below: 
 
fh==
λ
hcE ……..   (2).       Where h is plank’s constant  
When all kinds of different electromagnetic radiations come close to each other, they form 
different regions of different wavelength and various corresponding energy called 
electromagnetic spectrum. Each region of that energy corresponds and used for different 
spectroscopic techniques.(Wilson et al.,  2010).  
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The extent of electromagnetic spectrum from low- energy radio wave to high energy –
gamma rays radiation is illustrated in figure (2-2). 
 
 
Figure2. 2: The electromagnetic spectrum covers a continuous range of wavelengths, from 
low energy radio waves to gamma (c) rays at the high-energy end.(Wilson et al., 2010). 
 
 
The microwave region of the electromagnetic spectrum is associated with rotational 
spectroscopy, while the UV and Visible portions correspond to molecular electronic 
transitions. On another hand, The IR region, which is typically broken into near, mid, and 
far-IR, is utilized in vibrational spectroscopy .(Kerker et al., 2016). 
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Figure (2-3) shows electromagnetic spectrum and its usage for spectroscopic methods. 
 
 
 
 
Figure2. 3: The electromagnetic spectrum and its usage for spectroscopic methods 
(Henderson et al.,2006). 
 
 
 
 
 
 
 
 
 
 
 
16 
 
2.3 Molecular Vibration 
IR Spectroscopy is the analytical technique based on the atom's vibration of the molecule. 
When IR radiation passes through the sample fraction, an incident radiation at 
a particular frequency is absorbed.(Backx et al.,1977). As a result of this absorption, IR 
spectrum is obtained.  
There are two general types of molecular vibration: stretching and bending. Stretching is 
the rhythmical movement along the bond axis and can be symmetric or anti symmetric. 
Bending vibrations arise from a change in bond angle between two atoms or movement of 
a group of atoms, relative to the remainder of the molecule.(Gao et al., 1998).  
In stretching vibration, the frequency of a bond can be approximated via using Hooke's law 
as shown in wquation (3). This approximation treats the two masses and the connecting 
bond as a simple harmonic oscillator. It assumes that the two masses represent the atoms 
joined by a spring that represents the chemical bond; figure (2-4) illustrates simple 
harmonic approximation for diatomic molecules .(Djukic et al., 2005) 
 
 
Figure2. 4:Motions of a diatomic oscillator AB.(Djukic et al ., 2005). 
 
 
rKF ∆−= ……………   3               , where k is the force constant. 
When the restoring force causes the molecular motion to cease, the atom will begin 
moving in the opposite direction. This creates a smooth oscillatory motion known 
vibration.  
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The frequency of vibration related to the mass and the force constant of the spring are 
illustrated by equation (4). 
         µπ
kv
2
1
= …………. (4)               ,where µ is the reduced mass 
ba
ba
mm
mm
+
=µ  
 
 
In the classical harmonic osillciator, the energy of vibration given by equation (5) . 
 
 
   
hvrKE =∆= 2
2
1 ………….  (5) 
 
According to the last two equations, we can consider that the energy or frequency depends 
on how far one stretches or compresses the spring. If we look to equation (5) in a classical 
view, we can see that any value of r is possible and since this model is true, molecule can 
absorb any value of wavelength .(Dekker et al , 1981). 
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2.3.1 Normal mode of vibration: 
Normal modes are the pattern of motion in which all parts of the molecule move sinusoidal 
with the same frequency and with the fixed phase relation These modes vibrate 
independently and don’t interfere with each other [mathematically they 
form orthonormal basis.(Mills et al., 1985). 
The number of the normal mode is equal to the degree of freedom in the 
Cartesian coordinate. In Cartesian coordinate system, each atom can be displaced in the x-
 , y-, and z- directions corresponding to three degrees of freedom, Thus for 3D molecules 
with N atoms, there will be 3N normal modes , but not all for vibrational mode, three of 
them will be transitional mode, ZYX TTT ,, three will be rotational ZYX RRR  in nonlinear 
molecule, while only two transitional modes in the linear molecule are required, the 
remaining 3N-6 will be vibrational mode that is denoted by iv where i=3N-6 for nonlinear 
molecule and 3N-5 mode (degree of freedom)for linear one.(Banwell et al., 1994). 
 
The degree of freedom for polyatomic molecule, i.e. linear or nonlinear are summarized in 
table (2-1) 
 
Table2. 1: Degree of freedom for polyatomic molecule.(Banwell et al,. 1994). 
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2.3.2 Quantuem meechanical tretment of vibration: 
 
I-The harmonic approximation: 
According to the classical mechanics, a harmonic oscillator may vibrate with any 
amplitude. This means that it can have any amount of energy and large or small quantum 
mechanics. However, it shows that molecules can only exist in definite energy states 
[energy is quantized].(Ipnl et al., 2008). 
The quantum mechanical Hamiltonian for a one-dimensional harmonic oscillator and the 
Schrödinger equation are below given in the equations (7, 8).  
 
2
2
2
2
1
2
KX
dx
dH +−=
µ
 …… (6)                 0)
2
( 2
2
22
2
=Ψ−+ V
Vv kxE
dx
d

µµψ ….(7) 
 
 
Solving Schrodenger equation the energy state for harmonic potential will be described as 
equation (8). 
 
)
2
1( += iV nhvE  ………..   (8) 
 
Where in  is the vibrational quantum number which can take only positive integer values 
including zero, h is Planck's constant. The potential energy of harmonic oscillator is shown 
by the dashed line in figure (2-5) as a function of the distance between the atoms r. 
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II –Anharmonicity: 
The bond in real molecules disagrees with Hooke's law. When the two atoms approach 
each other, there must be a repulsive force between them. Thus, the vibrational energy will 
increase very rapidly and the molecule will deviate from harmonistic. The two atoms go 
far away from each other and the bond between them will be broken.(Herzberg et al., 
2013).  
The vibrational energy equals the dissociation energy. The actual variation of the potential 
energy as a function of the displacement of the atoms from their equilibrium positions is 
shown as the solid line in figure (2-5). The anharmonicity can be calculated by using the 
perturbation theory. The vibrational energy for diatomic molecule must be modified to 
apply the anharmonicity(Townes et al.,2013). The function which represents this is the 
Morse Function used in equation (9) as below:  
2)}](exp{1[ rraDE eqeq −−= ………  (9) 
 
Where eqD  is the dissociation energy, which is constant for a particular molecule,req is the 
equilbruim distance , a is the amplitude and r is the  stretching distance  
Using perturbation theory, the vibrational energy described in  equation (10) . 
 
)
2
1_(
2
1( eeeV wvwvE χ++= …………. (10) 
 
Where ew the oscillation frequency is expressed in wavenumbers and  eχ  is the 
anharmonicity constant  (Henry et al., 1968). 
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Both of harmonic and anharmonic approximation of molecular vibration is described in 
figure 2.5: 
 
 
 
 
 
 
 
Figure2. 5: The potential energy diagram comparison of the anharmonic and the harmonic 
oscillator. Vibration energy states are denoted by n(Henry et al.,1968). 
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2.4 FT-IR Spectroscopy 
 
Since the development of the first spectrophotometers in the beginning of  century, a 
rapid technological development has taken place. The first generations of spectrometers 
were dispersive ones. Initially, the dispersive elements were prisms, and later, they 
changed over the gratings.(Kačuráková et al., 2001). 
In the mid1960s IR spectroscopy witnessed a revival due to the advent of spectrometers 
that used the Fourier transform. The second-generation spectrometers, with an integrated 
Michelson interferometer, provided some significant advantages compared to dispersive 
spectrometer. The most important advantage of FT-IR spectroscopy for biological studies 
is that of almost any biological system can be obtained in a variety of 
environment.(Naumann et al.,1991). 
2.4.1 Infrared (IR) Spectroscopy: 
IR spectroscopy is certainly one of the most important analytical techniques available to 
today's scientist. One of the great advantages of IR spectroscopy is that its samples may 
be virtually studied; liquids, solution, pastes, powders, films, fibers, gases, and surface can 
all be examined through a judicious of sampling technique.(Siesler et al.,2008). 
2.4.1.1 IR-region: 
Infrared radiation spans a section of electromagnetic radiation spectrum next to the visible 
spectra region, and extends from wavelength, IR spectroscopes don’t usually use the 
wavelength to plot their spectra, but rather the inverse of wavelength; wave number; This 
measure has the advantage of being proportional to vibrational frequency and the 
vibrational energy. So, the wavenumber range of IR radiation is from about 12800 to 10
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1−cm     .IR spectrum is conveniently divided into three regions due to their place on visible 
spectrum near, mid, and far-IR regions ; The rough limits of each are shown in figure 
(2.6).( Stuart et al., 2005). 
2.4.1.2 IR Spectrum presentation: 
In IR spectroscopy, the horizontal coordinate of the spectrum runs from high wavenumbers 
to low wavenumbers according to the recommendation of the international union of pure 
and applied chemistry. This is equal to running from small wavelength to large wavelength 
(Villringer et al.,1993). 
IR absorption is generally presented in the form of a spectrum showing wavelength or 
wavenumber versus transmittance or absorption intensity The Transmittance (T), is the 
ratio of radiant power transmitted by the sample (I) to the radiant power incident on the 
sample ( )0I  Absorbance (A) is the logarithm to the base 10 of reciprocal of the 
transmittance (T) as shown in equation (11). 
 
 
0
101010 )
1(
I
IogTog
T
ogA  −=−== …………. (11) 
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 2.4.1.3 Theory of FT-IR  Spectroscopy: 
 
Interferometer is the heart of FTIR spectrometer. Basically, it works according to 
Michelson interferometer. Michelson interferometer takes a beam of light, splits it into two 
beams, and makes one of them travel a different distance than the other. The optical path 
differenceδ  is the difference in distance traveled by these two beams. (Griffiths et al., 
2007).  
Interferometer is the major component of most FTIR spectrometers, a diagram of a 
Michelson interferometer is shown in Figure (2-6) 
 
 
Figure2. 6: An optical diagram of Michelson interferometer. (Ferraro et al., 2012) 
The beamsplitter is designed to reflect half of the radiation that falls onto it 
and transmits the other. The transmitted light strikes the moving mirror and the reflected 
light strikes the fixed mirror. After reflecting off their respective mirrors, the two light 
beams interfere at the beam splitter, and then leave the interferometer to the sample 
compartment, interact with the sample, and continue to the detector. (Ferraro et al.,2012). 
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Zero path difference (ZPD) occurs when the reflected and the transmitted beam travel the 
same distance. The mirror displacement is the distance that the mirror moves ZPD relative 
to(Backx et al., 1977; Ferraro et al., 2012) ,and is denoted by ∆ .The relationship between 
mirror displacement and optical path difference is shown in equation (12). 
 
( ∆= 2δ )……….           (12) 
 
When the recombined beams, reflected off the fixed and moving mirrors, on the 
beamsplitter the two beams of light interfere the result will be a light beam of double   
amplitude (constructive interference) if the interferometer is in ZPD(Smith et al, 2011). 
This constructive interference also happens at the case of equation (13). 
 
( λδ ∗= n )………        (13) 
 
Where n is any integer with the values n= 0, 1, 2, 3……. 
 
 
 
A destructive interference occurs, and the amplitude for each beam cancels that of the 
other as can be seen in Figure 2.7  and equation (14) . 
 
λ)
2
1( +n ………       (14) 
 
Where n is any integer with the values n= 0, 1, 2, 3…. 
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 Figure2. 7: Destructive and constructive interference.(Smith et al., 2011) 
A combination of constructive and destructive interference occurs, making the light beam 
intensity somewhere very bright and very weak light beam. It allows the interferometer 
goes through the sample compartment and focuses upon the detector which measures the 
light intensity variation with optical path difference as cosine wave interferogram is 
Fourier transformed to give a spectrum.(Smith et al., 2011)  
Spectrum is calculated by Fourier transform of the interferogram. Ideally, the limits for 
Fourier transform integral should be plus and minus infinity.(Jaggi et al., 2006) The 
essential equations are related to the light intensity falling on detector I (t), to the spectral 
intensity B (ν) are equations (15) and (16). 
dvevBtI vti∫
+∞
∞−
Ω−= 2)()( ……..(15)                              dvetIvB vti∫
+∞
∞−
Ω−= 2)()( ……. (16) 
Where ν is the wavenumber 
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2.4.1.4 The working principe of FT-IR spectrometer: 
The basic components of an FT-IR spectrometer are shown in figure (2-8). The 
working principle of an FT-IR spectrometer is as follow. A steady illumination from a 
broad band-IR source is modulated by Michelson interferometer i.e. a beam splitter that 
divides the collimated light along different paths to two mirrors.(Griffith et al , 1996).   
The light reflected from the fixed and the moving mirror is recombined at the beam splitter 
and is directed through the sample and into the IR detectors. The path length difference 
between the light reflected from the fixed mirror and the moving mirror is measured very 
precisely(Kos et al.,2002). Next, the computer stores the digitized interferogram and 
converts it via Fourier transform to an IR spectrum(Černá et al., 2003) as described in 
figure (2.8). 
 
 
 
  Figure2. 8: FTIR layout and basic components.(Černá et al., 2003) 
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2.5 Ultraviolet visible spectrophotometer 
When continuous radiation passes through a transparent material, a portion of the radiation 
may be absorbed. In the case of UV-VIS spectrophotometer, the transitions that result in 
the absorption of electromagnetic radiation in this region of the spectrum are the ones 
between electronic energy level. As a molecule absorbs energy, an electron is promoted 
from an occupied orbital to an unoccupied one of a greater potential energy.(Saxena et al., 
2010) 
For most molecules, the lowest energy occupied molecular are orbital’s which correspond 
to the bonds. The orbital’s lie at somewhat higher energy levels. The orbitals that 
hold unshared pairs and nonbonding (n) orbital’s lie at even higher energy(Rossel et al., 
2006). 
The unoccupied , or antibonding orbitals ( ∗σπ and* ) ,are the orbitals of highest energy , 
figure(2.9) , shows a typical progression of electronic energy levels. 
 
 
Figure2. 9:Electronic energy levels . (Rossel et al., 2006) 
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In all compounds , the electronic may undergo several possible transitions of different 
energies Figure (2.10) show these transitions. 
 
 
Figure2. 10:Electronic energy transitions.(Pople et al., 1970). 
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A spectrophotometer is an instrument that measures the intensity of the light beam. It 
behaves as a function of wavelength Spectrophotometers for the measurement of 
absorbance in the UV-VIS range coming in a variety of configurations. The most common 
routine laboratory instruments are single-or double –beam devices made up of light source, 
monochromatic, sample compartment, detectors, data processor and display.(Kamentsky et 
al., 1965). 
The absorption of UV light by proteins has been analyzed in detail and proposed as a 
structural probe from the very early days of molecular biology. The absorption of proteins 
in the UV-VIS arises mainly from the electronic bands in the aromatic amino acid side- 
chains (tryptophan, tyrosine, and phenylalanine) and to less extent, cysteine residues, close 
to 290 nm.(Beaven et al.,1952).  
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2.6 Fluorescence  
Fluorescence spectrophotometer is one of the most widely used spectroscopic techniques 
in the field of biochemistry and molecular biophysics today(Li et al., 
2011). Fluorescence is a particular case of luminescence. The other case is the 
phosphorescence Luminescence which is an emission of ultraviolet, visible or infrared 
photons from an electronically excited species(Zhu et al., 2014). Fluorescence is a 
phenomenon whereby a material absorbs light at one wavelength and then emits it at a 
longer wavelength.(Eftink et al., 1981). 
The processe that accur between the absorption and emission of light are usually illustrated 
by the Jablonski digram , a typical jablonski digram is show in figure (2-11) (Dulkeith et 
al., 2002) .The singlet ground , first , and second electronic states are depicted by 0S , 1S
,and , respectively.At each of these electronic energy levels the fluorophores can exist in a 
number of vibrational energy levels , depicted by 0,1,2 ---- etc  The transtions between 
states are depicted as verticallines to illustrate the instantaneous nature of light 
absorption.(Anger et al., 2006). 
 
Figure2. 11: One form of a Jablonsik digram .(Genty et al., 1989) 
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The fluorescence lifetime and quantum yield are the most important characteristics of 
a fluorophore. Quantum yield is the amount of the emitted photons related to the number of 
the absorbed photons. The lifetime determines the time available for the fluorophore to 
interact with or diffuse in its environment, and then the information available from its 
emission(Magde et al., 2002). 
Following light absorption, several processes usually occur. A fluorophore is usually 
excited to some higher vibrational level of either 1S  or 2S .An interesting consequence of 
emission to higher vibrational ground states is that the emission spectrum is typically a 
mirror image of the absorption spectrum of the 10 SS →  transition (Morris et al.,1976). 
This similarity occurs because electronic excitation does not greatly alter the nuclear 
geometry. Hence the spacing of the vibrational energy levels of the excited states is similar 
to that of the ground state. As a result, the vibrational structures seen in the absorption and 
the emission spectra are similar.(Strickler et al., 1962). 
Upon excitation into higher electronic and vibrational levels, the excess energy is quickly 
dissipated, leaving the fluorophore in the lowest vibrational level of S1. This relaxation 
occurs in about 10–12 s and is presumably a result of a strong overlap among numerous 
states of nearly equal energy. Because of this rapid relaxation, emission spectra are usually 
independent of the excitation wavelength(Najbar et al., 1991). 
The intensity of fluorescence can be decreased by a wide variety of processes. This 
decrease in intensity is called quenching. Quenching can occur by different 
mechanisms. Collisional quenching occurs when the excited-state fluorophore is 
deactivated upon contact with some other molecule in solution, which is 
called the quencher(Boens et al., 2007). 
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For collisional quenching the decrease in intensity is described by the well-known Stern-
Volmer equation as described in equation (17). 
 
)(1)(1 0
0  svq kKF
F
+=+= τ    …….(17)  
 
In this expression svk  is the Stern-Volmer quenching constant, qk  is the bimolecular 
quenching constant, 0τ  is the unquenched lifetime, and   is the quencher concentration. 
The Stern-Volmer quenching constant  svk  indicates the sensitivity of the fluorophore to a 
quencher. In protein ,Tryptophan , PhenyPhenylalanine, and Tyrosine ; are the amino-acid 
reidues  that are responsible for the energy absorption and emission. 
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2.7 Proteins  
A protein is an organic compound has carbon, hydrogen, oxygen, nitrogen, and sometimes 
sulfur. A protein is made up of small molecules called amino acids as shown in figure 
(2.12). There are 20 different amino acids commonly found in the proteins of living things 
which have the same basic structure ( the amine group (NH2),central carbon atom (alpha-
carbon) and a carboxyl group (COOH)  ) .The difference between one  protein and another 
is  on the side chain (labeled R in the figure below)(Palau et al.,1982). 
 
 
 
Figure2. 12: General structure of all amino acids. Only the side chain, R, varies from one 
amino acid to another. Variable side chains give amino acids different chemical 
properties(Palau et al., 1982) 
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Amino acids bind together through covalent peptide bonds as shown in figure (2.13); they 
form a long chain called a polypeptide. Polypeptides have as few as 40 amino acids or as 
many as several thousand. Protein consists of one or more polypeptide chains. Sequence of 
amino acids in a protein’s polypeptide chain(s) determines the overall structure and 
chemical properties of the protein.(Surewicz et al., 1988). 
 
Figure2. 13:Primary protein structure.(Conte et al., 1999) 
 
Four levels of protein structure determine its four functions: the primary, the secondary, 
the tertiary, and the quaternary. The primary is the simplest level of protein structure and 
has a sequence of amino acids in a polypeptide chain. It's unique for each protein(Conte et 
al., 1999).Local folded structures that are formed within a polypeptide, due to the 
interactions between the carbonyl O of one amino acid and H of another one, is a 
secondary structure see figure (2.14). Its most common types are the α helix and 
the β pleated sheet. α helix and the β pleated sheet structures are held in shape by hydrogen 
bonds(Janin et al., 1990). 
 
Figure2. 14: Primary structure of protein, Beta sheet and α helix respectively(Surewicz et 
al ., 1988) 
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Tertiary structure is three-dimensional spaces see figure (2.15). It's formed as a result of 
interactions between the amino acids R groups. The interaction includes hydrogen 
bonding, ionic bonding, dipole-dipole interactions, and London dispersion forces. Proteins 
are made up of multiple polypeptide chains known as subunits. When subunits come 
together, they give protein its quaternary structure, such as hemoglobin and DNA 
polymerase.(Palau et al., 1982) 
 
 
 
Figure2. 15: Tertiary and quaternary structure of protein respectively.(Janin et al., 2000) 
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2.7.1  Human Serum Albumin: 
 
Albumin is the major soluble protein constituent of the circulatory system. Albumin has 
important functions in many fields of science such as pharmaceutical science, medical 
science, biology and chemistry, this functions  are related to the fixation and transport of 
numerous metabolites, hormones, endogenous and exogenous substances (e.g. 
pharmaceutical drugs, fatty acids, etc.…).(Carter et al., 1994). Albumin is a carrier of 
many drugs to different molecular targets.( Sudlow et al.,1976). 
Drugs binding and displacement reactions with serum albumins are important determinant 
of drug pharmacokinetics, restricting the unbound concentration, affecting drug 
distribution and elimination(Gillian et al.,1975).The general structure of albumin is 
characterized by several long α (alpha) helices, which allows it to maintain a relatively 
static shape.(Petitpas et al., 2001). 
Human serum Albumins (HSA) are the most abundant and prominent plasma proteins in 
mammals (about 60% of the total protein. HSA concentration in blood plasma is (40
mI
mg ). 
It also has a molecular mass of about 65 KDa and comprises 585 amino acid residues and 
it's synthesized in the liver. (Yamasaki et al., 1996). 
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HSA is soluble, a single and non-glycosylated polypeptide that is organized to form 
a heart-shaped protein with about 67% α-helix as its basic structure. It's a single 
polypeptide that is composed of three homologous domains (I-III) connected by flexible 
hinge region that forms a heart-shaped structure in aqueous solution. Each domain has two 
sub-domains (A and B) which have common structural motifs by various forces such as 
salt bridges and hydrophobic interactions.(Sugio et al., 1999). 
HSA is a tertiary structure at 2.5 Å resolutions. Its complete three–dimensional structure 
has recently been determined by X-ray crystallography, and the binding sites for several 
drugs were also localized as seen in Figure(2-16 )(Abou-Zied et al., 2008): 
 
 
Figure2. 16: Schematic drawing of the HSA molecule. Each sub domain is marked with a 
different color (Abou-Zied et al., 2008) 
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Investigation of the binding interaction between drugs and serum albumin is very 
important in pharmacology and pharmacodynamics. Distribution of drugs is 
controlled by HSA. Because most drugs that travel in plasma bind to the sites, hydrophobic 
compounds will not freely dissolve in the bloodstream. The abundance and flexibility of 
human serum albumin allow these molecules to bind to it and carried in the bloodstream 
throughout the body.( He et al., 1992) . 
The drug binding and displacement reactions with HSA strongly influence the distribution, 
the elimination and the pharmacological effect of the drug. The binding process affects 
drug movement into tissues and the compound's therapeutic efficacy, 
toxicity, and pharmacokinetics.(Bhattacharya et al., 2000) .HSA is capable of binding 
reversibly a variety of drugs, resulting in an increased solubility in plasma, decreased 
toxicity, and/or protection against oxidation of the bound ligand.(Zsila et al., 2003). 
The protein's ability of binding aromatic and heterocyclic compounds largely depends 
on the existence of two major binding regions, namely Sudlow, s sites I and II. Site I is 
known as the warfarin binding site. It is formed by a pocket in subdomain IIA 
and contains the only tryptophan of HSA (Trp 214). Site II is 
located in subdomain IIIA and is known as the benzodiazepine binding site as shown in 
figure (2.17).(Kragh et al., 1990). 
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Figure2. 17: The drugs binding sites determined on the HSA structure.( He et al.,1992) 
 
 
Bulky heterocyclic anions bind to site I (located in subdomain IIA), whereas site II 
(located in subdomain IIIA) is preferred by aromatic carboxylates with an extended 
conformation.( He et al , 1992) 
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Chapter Three: Experimental Part 
 
This section consists of three parts, the first one includes information about the sample that 
I used and thin film preparation, the second one contains a full description about the 
spectroscopic techniques that I used in this work, which are (Bruker IFS 66/S FT-IR 
spectrophotometer), UV-VIS spectrophotometer (NanoDropND-1000), and 
Fluorospectrometer (Nano Drop 3300). 
The final section presents the experimental procedure in details. 
 
Rules for Solutions prepration 
When we preparing any solution, we must place the solid (solute) first then add the liquid 
which is the solvent (buffer) to reach the indicated mark as shown in below figure . We 
can’t add the solute to the solvent otherwise the final volume will be a little larger than 
what is supposed to be which means the final molarities will be different.  
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3.1 Samples and materials 
 
HSA protein, Procaine, and Dopamine in powder form were purchased from Sigma 
Aldrich chemical company and they were used without further purifications. The data were 
collected using samples in two forms, the first one in thin film form for FT-IR technique 
and the second one in liquid form for both UV-VIS and fluorescence measurements. 
3.1.1 UV-VIS and FLU Techniques: 
 
3.1.1.1 Preparation of HSA Stock Solution: 
 
HSA protein was prepared in a concentration of [1.2mM] as stock one by dissolved [0.08g] 
of protein in [1mL] phosphate buffer saline PH (7.4), in order to get a final concentration 
of [0.6mM] in final Drug-HSA complex solution . 
3.1.1.2 Preparation of HSA final concentration : 
 
HSA protein solution with animal concentration of [40mg/mL] was prepared by dissolved 
[0.04 g] of protein in powder form in [1mL] buffer saline. 
3.1.1.3 Prepration of Procaine stock solutions: 
 
Procaine with molecular weight of (272.28 g/mole) and morality of [4.8mM] were 
prepared by dissolved [0.0131 gram] of procaine in [10ml] volumetric flask of buffer 
saline PH (7.4) , then it's used to prepare different concentrations of procaine drug using 
dilution equation as shown in equation (3.1) and  table (3.1): 
 
 
 
M 2211 VMV ×=× ……… (1) 
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Table3. 1: Procaine Standard Solutions. 
 
 Pro initial Pro Final  
4.8 mM 
stock 
 
3.6 
 
I took [0.75ml] from the stock Pro and place it in [1ml] 
Volumetric flask. 
Fill to the mark with saline (bottom of meniscus)  
 
3.6 
 
2.4 
 
I took [0.67ml] from the 3.6 mM and place it in 1 ml 
volumetric flask 
Fill to the mark with saline 
 
2.4 2.0 
 
I took [0.83ml] from the 2.4 mM and place it in 1 ml 
volumetric flask 
Fill to the mark with saline 
 
2.0 1.2 
 
I took [0.6ml] from the 2.0 mM and place it in 1 ml 
volumetric flask 
Fill to the mark with saline 
 
1.2 1 
 
I took [0.83ml] from the 1.2 mM and place it in 1 ml] 
volumetric flask 
Fill to the mark with saline 
 
1.0 0.8 
 
Take [0.8ml] from the 1.0 mM and place it in 1 ml volumetric 
flask 
Fill to the mark with saline 
 
0.8 0.6 
 
Take [0.75ml] from the 0.8 mM and place it in 1ml 
volumetric flask 
Fill to the mark with saline 
0.6 0.3 
 
Take [0.5ml] from the 0.6 mM and place it in 1ml   
volumetric flask 
Fill to the mark with saline 
 
3.1.1. 4 Preparation of Procaine –HSA complex solutions:  
To prepare the complexes, we kept HSA as close as possible to 0.6 mM (the concentration 
in plasma).  Mix [50 lµ of the HSA stock + 50 lµ  of each of the Pro standards sol’n] the 
molarities of them will be halved to be as described in table 3.2: 
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Table3. 2: preparing Pro-HSA complexes. 
 
 Pro sol’n  
(mM) 
HSA 
stock 
(mM) 
Volume 
HSA 
stock 
Volume 
Pro Soln 
 
Final 
total 
volume  
Final 
HSA 
(mM) 
Final 
Pro 
(mM) 
[Pro]/[HSA] 
4.8 
 
1.2 50 lµ   50 lµ   
 
100 lµ   
 
0.6 
 
2.4 
 
2.4/0.6 = 4.0 
3.6 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ  
 
0.6 1.8 
 
1.8/0.6 = 3.0 
2.4 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ  
 
0.6 1.2 
 
1.2/0.6 = 2.0 
2.0 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ  0.6 1.0 
 
1.0/0.6 =1.67 
1.2 
 
1.2 50 lµ  
 
50 lµ  
 
100 lµ  
 
0.6 0.6 
 
0.6/0.6 = 1.0 
1.0 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ   
 
0.6 0.5 
 
0.5/0.6 = 0.83 
0.8 
 
1.2 50 lµ   
 
50 lµ   
 
100 lµ  0.6 0.4 
 
0.4/ 0.6=0.67 
0.6 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ   0.6 0.3 
 
0.3/ 0.6 = 0.5 
0.3 
 
1.2 50 lµ  
 
50 lµ  
 
100 lµ  
 
0.6 0.15 
 
0.15/0.6=0.25 
 
 
3.1.1.5 Preparation of Dopamine Stock Solution:   
Dopamine with molecular weight of [189.2g/mole] and molarity of [4.8mM] were 
prepared by dissolved [0.0091g] of dopamine in [10ml] volumetric flask of buffer saline 
PH (7.4)as stock solution then it used to prepare different concentrations of DA using 
dilution equation as Pro drug, see equation (2) and table 1.2 
M 2211 VMV ×=×  ……….(2) 
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Table3. 3: Dopamine Standard Solutions. 
 
 DA initial DA Final  
4.8 mM 
stock 
 
3.6 
 
I took [0.75ml] from the stock DA and place it in [1ml] 
Volumetric flask. 
Fill to the mark with saline (bottom of meniscus)  
 
3.6 
 
2.4 
 
I took [0.67ml] from the 3.6 mM and place it in 1 ml 
volumetric flask  
 
Fill to the mark with saline 
 
2.4 2.0 
 
I took [0.83ml] from the 2.4 mM and place it in 1 ml 
volumetric flask 
 
 Fill to the mark with saline 
2.0 1.2 
 
I took [0.6ml] from the 2.0 mM and place it in 1 ml volumetric 
flask 
 
Fill to the mark with saline 
1.2 1 
 
I took [0.83ml] from the 1.2 mM and place it in 1 ml] 
volumetric flask 
 
Fill to the mark with saline 
1 0.8 
 
Take [0.8ml] from the 1.0 mM and place it in 1 mL volumetric 
flask Fill to the mark with saline 
 
0.8 0.6 
 
Take [0.75ml] from the 0.8 mM and place it in 1mL 
volumetric flask 
 Fill to the mark with saline 
0.6 0.3 
 
Take [0.5ml] from the 0.6 mM and place it in 1mL   
volumetric flask Fill to the mark with saline 
 
3.1.1.6 Preparation of Dopamine –HSA complex solutions:  
To prepare the complexes, we kept HSA as close as possible to 0.6 mM (the concentration 
in plasma).  Mix [50 lµ   of the HSA stock + 50 lµ of each of the DA standards sol’n] the 
molarities of them will be halved to be as described in table 3.4: 
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Table3. 4: Preparing of  DA-HSA complexes. 
 
 DA sol’n  
(mM) 
HSA 
stock 
(mM) 
Volume 
HSA 
stock 
Volume 
DA Soln 
 
Final 
total 
volume  
Final 
HSA 
(mM) 
Final 
DA 
(mM) 
[DA]/[HSA] 
4.8 
 
1.2 50 lµ  50 lµ  
 
100 lµ  
 
0.6  
 
2.4 
 
2.4/0.6 = 
4.0 
3.6 
 
1.2 50 lµ   
 
50 lµ   
 
100 lµ  
 
0.6 1.8 
 
1.8/0.6 = 
3.0 
2.4 
 
1.2 50 lµ  
 
50 lµ  
 
100 lµ  
 
0.6 1.2 
 
1.2/0.6 = 
2.0 
2.0 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ   
 
0.6 1.0 
 
1.0/0.6 = 
1.67  
1.2 
 
1.2 50 lµ   
 
50 lµ  
 
100 lµ  
 
0.6 0.6 
 
0.6/0.6 = 
1.0 
1.0 
 
1.2 50 lµ  
 
50 lµ   
 
100 lµ  
 
0.6 0.5 
 
0.5/0.6 = 
0.83 
0.8 
 
1.2 50 lµ  
 
50 lµ   
 
100 lµ  0.6 0.4 
 
0.4/ 0.6 = 
0.67 
0.6 
 
1.2 50 lµ  
 
50 lµ  
 
100 lµ  
 
0.6 0.3 
 
0.3/ 0.6 = 
0.5 
0.3 
 
1.2 50 lµ  
 
50 lµ  
 
100 lµ   
 
0.6 0.15 
 
0.15/0.6= 
0.25 
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3.1.2 FT-IR Technique: 
 
HSA stock solution [1.2mM] , final one [0.6mM] , DA and Pro drugs complexes for IR 
spectroscopic technique also prepared in such way of UV-VIS and fluorescence technique 
as described in tables [3.1, 3.2, 3.3, and 3.4] 
3.1.2.1 Thin film preparation: 
 
Silicon windows (NICODOM Ltd) were used as spectroscopic cell windows, 60µl of each 
sample of HSA-procaine complex solution and Dopamine-HSA complex solution was 
spread on silicon window using spincoater to get homogenous thickness for all samples as 
possible as I could, then incubator was used to evaporate the solvent in order to obtain 
transparent thin film on the silicon window. All solutions were prepared at the same time at 
room temperature and they stored at same conditions. 
3.2 Instruments 
 
Many instruments can be used to study the interaction between HSA and the drugs.  In this 
work the   following instruments have been used to take the data.                 
 
3.2.1 FT-IR spectrometer: 
 
FT-IR measurements were obtained used Bruker IFS 66/S spectrophotometer equipped 
with a liquid nitrogen-cooled MCT detector and KBr beam splitter. Data were analyzed 
using Bruker IFS 66/S software and origin program. 
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3.2.2 UV-VIS spectrophotometer (Nano Drop ND-1000): 
 
The absorption spectra for HSA with two drugs were obtained by using of Nano Drop ND-
1000 Spectrophotometer at Nanotechnology Lab. Spectrophotometer used to measure the 
absorption spectrum of protein and two drugs complex solution in the range between 220 -
750nm with high accuracy. 
 
3.2.3 Fluorospectrometer (NanoDrop 3300): 
 
Fluorescence measurements were obtained using NanoDrop ND-3300 
Fluorospectrophotometer at Nano technology lab, the excitation source of this instrument 
is one of three solid state lights emitting diode (LED). UV-LED with maximum excitation 
of (365) nm. Blue-LED with maximum excitation of (470nm), and white LED which has a 
range of excitation between (500-650nm). 
 
Many instruments also used in this work such as spincoater to make the thin films sample 
homogenous as possible as we can also digital balance, vortex, and Micropipettes. 
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3.3 Expermental Procedure 
 
3.3.1 UV-VIS Spectrophotometer experimental procedure: 
 
The procedure of UV-VIS spectrophotometer which used in this work was described in 
Nano Drop 1000 spectrophotometer (V3.7, 2008, User's manual, Nano Drop 1000 
spectrophotometer 3.7, User manual, 2008) as follows: 
Operation 
 1 µ l sample of Procaine and Dopamine was pipette into the end of a fiber optic cable (the 
receiving fiber). A second fiber optic cable (the source fiber) is then brought into contact 
with the liquid sample causing the liquid to bridge the gap between the fiber optic ends. 
 The gap is controlled to both 1mm and 0.2 mm paths. A pulsed xenon flash lamp provides 
the light source and a spectrometer utilizing a linear CCD array is used to analyze the light 
after passing through the sample. The instrument is controlled by PC based software, and 
the data is logged in an archive file on the PC.                                     
Basic Use: The main step for using UV-VIS spectrophotometer is described in (NanoDrop 
1000 Spectrophotometer 3.7, user manual 2008) as follows: 
1. Open the sample arm then pipette the sample of Procaine or Dopamine onto the lower 
measurement pedestal as described on the first photo of fig (3.1). 
2. Close the sampling arm and initiate a spectral measurement using the operating software 
on the PC. The sample column is automatically drawn between the upper and lower 
measurement pedestals and the spectral measurement made; see the second photo of fig 
(3.1). 
3. When the measurement is complete, open the sampling arm and wipe the sample from 
both the upper and lower pedestals using a soft laboratory wipe. Simple wiping prevents 
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sample carryover in successive measurements for samples varying by more than 1000 fold 
in concentration see the last photo of figure (3.1)(Scientific, 2009). 
 
 
 
 
Figure3. 1: Main steps for using the sample UV-VIS Spectrophotometer . (Scientific, 
2009) 
 
 
3.3.2 Fluorospectrophotometer experimental procedures: 
 
The experimental procedure of fluorospectrophotometer was described in details in (Nano 
Drop 3300 fluorospectrophotometer V3.7 user manual, 2008) as follows: 
Operation 
 1-2 lµ  sample of Procaine or Dopamine is pipette onto the end of the lower measurement 
pedestal (the receiving fiber). A non-reflective “bushing” attached to the arm is then 
brought into contact with the liquid sample causing the liquid to bridge the gap between it 
and the receiving fiber. 
The gap or path length is controlled to 1mm. Following excitation with one of the three 
LEDs, emitted light from the sample passing through the receiving fiber is captured by the 
spectrometer. Nano Drop 3300 is controlled by software run from a PC. All data is logged 
and archived in the C:\ND-3300 Data folder as well as at a second user defined location. 
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Basic Use: 
The main steps for making a measurement are listed below as described in (NanoDrop 
3300 spectrophotometer V3.7 user manual, 2008) and the photos show it clearly. 
 
1. With the sampling arm open, pipette the sample of Procaine or Dopamine onto the lower 
measurement pedestal see the first photo of fig (3.2). 
 
2. Close the sampling arm and initiate a measurement using the operating software on the 
PC. The sample column is automatically drawn between the upper bushing and the lower 
measurement pedestal and the measurement is made, see the second photo of fig (3.2). 
 
3. When the measurement is complete, open the sampling arm and blot the sample from 
both the upper bushing and the lower pedestal using low lint laboratory wipe, see the last 
photo of figure (3.2). 
 
 
Figure3. 2: Main steps for using the sample  flurospectrophotometer (Nano Drop 3300 
fluorospectrophotometer V3.7 user manual, 2008) 
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3.3.3 FT-IR Spectrometer experimental procedures: 
 
The absorption spectra of HSA with drugs were obtained in the range of (400-4000) 1−cm
these spectra were taken as an average of 65 scans. Fourier Self –deconvolution, Baseline 
correction, peak picking, and normalization were applied for all spectra by OPUS software, 
the peak positions were determined by peak picking after we applied the deconvolution for 
6 times for each spectrum since we found that this time is the best to give us the best 
information about the secondary structures.    
 IR-Spectra for HSA ,Dopamine-HSA complexes ,and Procaine –HSA complexes were 
obtained in the range of (1200-1800 ) 1−cm , we divides it  into three amides(1700-1600)
1−cm  represent amide I,(1600-1480) 1−cm  represent amide II and (1330-1220) 1−cm
represents  amide III 
3.3.4 FT-IR data processing: 
 
Analysis of IR spectra in term of protein structure is not straightforward and required much 
technique to help with both quantitative and qualitative interpretation of spectra; in this 
work many data processing tasks were used.                                                                   
3.3.4.1 Baseline correction:   
 
Using baseline correction processing data, the baseline of the resultant spectra be flat line 
on zero, on other word there no signal. Baseline correction processing data is applied in 
two steps. Recognize the baseline which can be done by selecting a point from spectral 
points on the spectrum then adding or subtracting an intensity value from the point or 
points to correct baseline offset. Baseline corrections done automatically using Opus User 
Software (OPUS). (Lei et al., 2010) 
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3.3.4.2 Peak picking: 
 
Processing data used to find the position of the peak for the spectra. Automated process 
applied in two steps, recognition of peaks, and determination of the wavenumbers values 
of maximum or minimum absorbance. (Lei et al., 2010) . 
Before applying peak picking process for spectra, the deconvolution for six times must be 
applied. 
 
3.3.4.3 Second derivative: 
 
Second derivative used to resolve and analyze the complex protein spectrum in the range 
of near infrared region by separating the overlapping bands. Second derivative is used in 
many of quantitative and qualitative determination of protein. (Balestrieri et al.,1978) 
 
3.3.4.4 Fourier Self Deconvolution: 
 
Processing data to resolve overlapping of bands for spectra that have narrow bands to 
distinguish the spectral features. Fourier Self deconvolution applied using several steps, 
computation of an interferogram of the sample by computing the inverse Fourier-transform 
of the spectrum, and multiplication of the interferogram by a smoothing function and by a 
function consisting of a Gaussian–Lorentzian band shape, and Fourier transformation of 
the modified interferogram (Abdul‐Fattah et al., 2007).  
 
In order to get the best results in this work the deconvolution has been applied six times 
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Fourier self-deconvolution technique has been successfully applied in both quantitative and 
qualitative study of large number of protein it’s give information about the change in 
secondary structure of that protein and also it useful for giving information of change 
according to other factor such as temperature, PH, ligand binding and others. (Kauppinen 
et al., 1981) 
 
3.3.4.5 Spectral subtraction: 
 
Straight forward process for analysis of complex spectra, approach that is very useful for 
investigating subtle differences in protein structure. Spectral subtraction basic principle is 
the subtraction of a protein absorbance spectrum in state A from that of the protein in state 
B, the resultant spectra of this process only shows peaks that are associated with those 
groups involved in the conformational change. (Martin et al , 1994). 
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Chapter Four: Results and Discussion 
 
This chapter includes the main results analysis and discussions of our data. The first 
section includes the results that obtained from the UV-VIS spectrophotometer and we 
discussed it in details in that section, the second one deals with fluorescence 
spectrophotometer data and results, in the final section FT-IR graphs and data analysis are 
given. 
4.1 UV-VIS technique 
 
The interaction between protein and drugs plays important role and factor for both 
pharmacokinetics and pharmodynamics, so many researches had studied the interaction 
between that protein and drugs, UV-VIS spectroscopy was one of effective method used to 
investigate that interaction because of its high sensitivity, rapidity, and ease of 
implementation.(Rasoulzadeh et al., 2010 ,Suryawanshi et al., 2016 )  
The absorption spectra of different concentration of procaine and dopamine with fixed 
concentration of HSA are displayed in figure (4.1)and figure (4.2), respectively, the 
excitation has been done on 210 nm on other hand the absorption was done on 280 nm. It’s 
shown from the figures that as the concentration of procaine and dopamine increased the 
UV intensity of HSA increases, this increment and change of absorbance can be 
determined as an indicator of interaction occurred between HSA protein and two drugs. 
We repeated the measurements for all samples many times and it was clearly that there is 
no change of the consistent of the results and no significant differences were observed. 
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The absorbance spectra of HSA-Procaine complex have been drawn using origin software 
program as shown in figure (4.1). 
 
 
Figure4. 1: UV-Absorbance spectra of Procaine-HSA complexes at these concentration (a= 
Free Procaine, b= Free HSA, c=0.3 mM, d=0.4-mM, e=0.5 mM,f=0.6 mM, g=1 mM, 
h=1.2 mM). 
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HSA –DA complex spectra for different concentration of DA has been drawn using origin 
software as shown in figure (4-2). 
 
 
 
 
Figure4. 2: UV-Absorbance spectra of Dopamine-HSA complexes at these concentrations 
(a= Free DA 2.4mM, b= HSA Free, c= 0.3 mM, d= 0.4mM, e=0.5 mM, 
f=0.6 mM, g=1mM, h=1.2mM, i=2.4mM). 
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4.1.1 Binding constants of procaine, Dopamine and HSA complexes using 
UV-VIS technique: 
 
(Procaine or dopamine)-HSA complexes binding constant were determined using UV-VIS 
spectrophotometer results according to published method (Stephanos et al., 1996), by 
assuming that there is only one type of interaction between procaine or dopamine and HSA 
in aqueous solution, which leads to establish equations (1) and (2) as follows. 
 
     HSA +Procaine↔  Procaine +HSA                …………….     (1)  
     HSA+Dopamine↔  Dopamine +HSA 
 
   K = [Procaine: HSA] / [Procaine] [HSA]       ………………     (2) 
   K = [Dopamine: HSA] / [Dopamine] [HSA]  
 
The absorption data were treated using linear double reciprocal plots based on the 
following equation (Marty et al., 2009 ). 

1
)(
111
000
×
−
+
−
=
− ∞∞ AAkAAAA
 ……. (3) 
 
 
Where 
0
A  corresponds to the initial absorption of protein at 280nm in the absence of 
ligand, A∞ is the final absorption of the ligand protein, and A is the recorded absorption at 
different procaine or dopamine concentration (L).                                                             
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4.1.1.1Procaine binding constant: 
 
Binding constant calculations of procaine were determined using equation (3) as described 
in table (4.1): 
Table4. 1: Binding constant calculations for Procaine-HAS complexes. 
 
 
Sample[mM] 
 
Absorbance 
(A) 
 
A-A0 
 
1/(A-A0) 
 
(1/ L) × 310+  
{L/mole} 
 
b- Free HSA 
 
 
18.36 [A0] 
 
--------- 
 
---------- 
 
----------- 
 
c-0.30 
 
20.68 
 
2.32 
 
0.30 
 
3.00 
 
 
d-0.40 
 
 
22.00 
 
4.00 
 
0.25 
 
2.50 
 
e-0.50 
 
23.00 
 
4.60 
 
0 .20 
 
2.00 
 
f-0.60 
 
25.00 
 
6.40 
 
0.14 
 
1.60 
 
g-1.00 
 
 
26.00 
 
7.64 
 
0 .12 
 
1.00 
 
h-1.20 
 
 
27.00 
 
8.64 
 
0.11 
 
0 .80 
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Using linear regression software program, the double reciprocal plot of 1/ (A-
0
A ) sV  (1/L) 
has been fitted to get the best linear curve as shown in figure (4.3).                                                                         
 
 
 
Figure4. 3: The plot of 1/ (A-A0) vs. 1/L for HSA with different concentration of procaine 
 
linear fitting for the points of HSA-Procaine complex has been found to be as described in 
next equation: 
Y=0.0801786+0.080020267x  
   Intercept = 0.0801786                                                     Slope = 0.080020267 ×10-3 
 
Using last equation binding constant (K) can be estimated from the ratio of the intercept to 
the slope to be [1.00115599× 310 ] for procaine –HSA complexes. 
 
The value obtained is indicative of a weak procaine protein interaction with respect to 
other drug-HSA complexes with the binding constant in the range of 510  and 1710 −M
(Zhong, 2004). 
(1/L) (mM)-1 
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4.1.1.2 DA binding constant: 
 
Binding constant calculations of Dopamine were determined using equation (3) as 
described in table (4.2) : 
 
Table4. 2: Binding constant calculations for DA-HSA complex. 
 
 
Sample × 310−
[mole / L] 
 
Absorbance 
(A) 
 
A-A0 
 
1/(A-A0) 
 
1/ L× 310+  
{L/mole} 
 
b- Free HSA 
 
 
23.014 [A0] 
 
-------- 
 
---------- 
 
----------- 
 
c-0.30 
 
28.89 
 
5.88 
 
0.17 
 
3.33 
 
d-0.40 
 
 
30.15 
 
7.14 
 
0.14 
 
2.50 
 
e-0.50 
 
31.34 
 
8.33 
 
0 .12 
 
2.00 
 
f-0.60 
 
33.01 
 
10.00 
 
0.10 
 
1.66 
 
g-1.00 
 
35.83 
 
 
12.82 
 
0 .08 
 
1.00 
 
h-1.2 
 
 
37.29 
 
14.28 
 
0.07 
 
0.83 
i-2.4 
 
43.01 20.00 0.05 0.42 
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The double reciprocal plot of 1/ (A-
0
A ) sV  (1/L) has been obtained using linear regression 
software program to get the best linear line as shown in figure (4.4). 
 
 
Figure4. 4: The plot of 1/ (A-A0) vs. 1/L for HSA with different concentration of 
Dopamine 
 
Linear equation of last reciprocal plot has been determined using linear regression program 
to be as described in the next equation. 
Y=0.034956 +0.0411710x 
       Intercept = 0.034956                                                  Slope= 0.0411710×10-3 
 
The binding constant (K) can be estimated from the ratio of the intercept to the slope to be 
(0 .849044×103) for Dopamine –HSA complexes  
Binding constant value of DA is indicative of a weak Dopamine protein interaction with 
respect to other drug-HSA complexes with the binding constant in the range of 510  and 
1710 −M  (Zhong et al., 2004 ) 
 
(1/L) (mM)-1 
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4.2 Fluorescence spectroscopy 
 
Investigation of the binding mode between the proteins and drug has been attracted the 
interest of research for many years because it's extremely important to understand 
biopharmceutics, pharmacokinetics and toxicity of the drug as well as the relationship of 
structure and function of the protein. (Cheng et al., 2017)                                                                             
Fluorescence absorption spectroscopy is a powerful tool for studding the interaction 
between   the drugs and HSA protein, many drugs are not fluorescent but proteins have a 
fluorescent character that results from the protein's tryptophan and tyrosine residues so the 
auto fluorescence of HSA is originated from Tryptophan (Trp), Tyrosine (Tyr) 
residues.(Cheng et al., 2017 , Sułkowska et al.,  2002  , Maltas et al., 2014 ) 
 
The emission spectra were obtained in the range of (350 to 750) nm the excitation 
wavelength at 360nm and the emission one was obtained at wavelength of 439 nm, and 
appropriate blank corresponding to buffer were subtracted to correct background 
fluorescence.(Yang et al., 2013 )                                                                                                                         
 
Quenching is the decrease of intensity of fluorescence it's classified into static and 
dynamic. Dynamic leads to no change in absorption spectra but in our work as shown in 
figure (4.5) and (4.6) as increasing the concentration of drugs the absorption intensity of 
the protein is decrease so that quenching is concern as static one.(Maltas et al., 2014 ) 
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Decreasing protein intensity with increasing of concentration indicates that the two drugs 
bind to protein, and that the microenvironment around the tyrosine residue was disturbed 
and the hydrophobicity of the residue decreased in the presence of procaine or dopamine, 
yet the microenvironment around the tryptophan residues had no discernable change from 
the binding process.(Maltas et al., 2014 ). 
 
Fluorescence emission spectra of HSA with different concentration of Procaine has been 
drawn to get figure (4.5). 
 
 
Figure4. 5: Fluorescence emission spectra of HSA in the presence of various concentration 
of procaine (a=Free HSA , b=0.3 mM, c= 0.4 mM, d= 0.5 mM, e=0.6mM, f= 1 mM, g= 1.2 
mM, h= 2.4 mM, i=free Pro). 
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Fluorescence emission spectra of HSA with different concentration of Dopamine is shown 
in figure (4.6) 
 
 
Figure4. 6: Fluorescence emission spectra of HSA in the presence of various concentration 
of Dopamine (a= Free HSA, b= 0.3mM, c=0.4 mM, d=0.5mM, 
e=0.6 mM, f=1 mM, g= 1.2mM, h= 2.4mM, i=free DA 4.8mM). 
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4.2.1 Stern –Volmer quenching constant (Ksv) and the quenching rate 
constant of the bimolecular (Kq): 
 
Quenching is the decrease of intensity of fluorescence for given substance. Refer to any 
process that does that decrease. This process included excited state reactions, energy 
transfer, complex formation, and collisional quenching. Also, it can be produced by the 
binding of a molecule, known as quencher (procaine and dopamine), to the fluorescent 
molecule (HSA protein) from collisional encounters between the fluorophore and the 
quencher, this called as collisional or dynamic quenching. (Mote et al., 2010 )  
 
Stern –Volmer quenching equation is usually used to analyze the fluorescence data to get 
quenching parameters, this decrease of intensity of fluorescence can be described by 
equation (4):       
 
)(1)(1 0
0  svq KKF
F
+=+= τ ……… (4) 
 
In the above expression 0F and F are the relative fluorescence intensities in the absence 
and presence of quencher, [L] is the concentration of quencher , SVK is the Stern-Volmer 
dynamic quenching constant , qk  is the bimolecular quenching rate constant, and 0τ is the 
average bimolecular lifetime in the absence of quencher . Stern –Volmer quenching 
constant Ksv indicates the sensitivity of the fluorophore to quencher. 
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4.2.1.1 Procaine's Calculations for binding quenching rate constant: 
 
Using Stern–Volmer quenching equation calculations for determining binding quenching 
rate constant were determined. 
Using linear regression program process linear curve has been plotted as shown in figure 
(4.7). 
 
L 
Figure4. 7: The Stern-Volmer plot for procaine –HSA complexes 
 
Using equation (4) Stern-Volmer quenching constant Ksv assumed to be the slope of 
 (4.7) linear figure as described in below equation. 
Y=1.0025596+0.0056648x 
Slope =0.00566× 310+   = SVK  = 0τqk  
Using above relation, we can calculate the value of qk using the fluorescence life time of 
810− for HAS. (Han, 2016 , Li, 2014 ) 
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Which is smaller than the maximum dynamic quenching constant for various quenchers 
with biopolymer (2 111010 −−× smo ), (Tan, 2012 ).Which implies that (Wang et al.,2007) 
 
4.2.1.2 Dopamine Calculations for binding quenching rate constant: 
 
Using Stern–Volmer quenching equation calculations for determining binding quenching 
rate constant were determined.Using linear regression program process the linear curve has 
been plotted   as shown in figure (4.8). 
 
L 
Figure4. 8: The Stern-Volmer plot for Dopamine –HSA complexes. 
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Stern-Volmer quenching constant Ksv was obtained by the slope of the curve obtained 
from figure (4.8) as described in below equation:  
Y=1.0039834+0.0104665x 
                  Slope= 0.0104665× 310   = SVK = 0τqk 0
3 /1001046650 τ×⋅=qK  
9
8
3
10046651
10
1001046650
×⋅=
×⋅
=
−qK  
Previous value is smaller than the maximum dynamic quenching constant for various 
quenchers with biopolymer (2 111010 −−× smo ).(Wang, 2007).The value of quenching 
constant implies that quenching is not initiated by dynamic collision but its form 
contribution of static and dynamic.(Wang et al., 2007) 
4.2.2 Determination of the binding constant using fluorescence 
spectrophotometer: 
 
When static quenching is dominated as quenching type of fluorescence for HSA protein 
with two drugs the Weave -Burker can be used as equation (5). (Azimi et al., 2011) 
 
000
111
FKFFF
+=
− 
 ……… (5) 
 
Where K is the binding constant of procaine or dopamine with HSA, and can be calculated 
by plotting 1/ (F0-F) vs. 1/L, see figure (4.9) and figure (4.10).The value of K equals the 
ratio of the intercept to the slope.  
 
 
Van der Waals interaction and hydrogen bond is the main reason for binding between the 
protein and two drugs. ( Azimi et al., 2011 ).  
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4.2.2.1 Procaine binding constant calculations: 
 
Calculation for binding constant of HSA-Procaine complex for different concentration of 
procaine have been done using equation (5) . 
The binding constant K of procaine with HSA can be calculated by plotting 1/ (F0-F) vs. 
1/L. Using linear regression program best linear curve was plotted as shown in figure (4.9). 
 
 
Figure4. 9: plot for 1/ (F0-F) vs. L-1 
 
 
The value of K equals the ratio of the intercept to the slope. 
 
y=0.06475007522974+0.056889886808176x 
 
Slope= 0.056889886× 310−                                       intercept= 0. 0647500 
K=Intercept/Slope = 1.13818×103 
 
Which nearly agree with the values obtained earlier by UV technique.                                                                                                                        
(1/ L) mM 
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4.2.2.2  Dopamine binding constant calculations: 
 
Calculations for determining binding constant of DA with HSA Protein has been 
determined using equation (5)  
The binding constant K of Dopamine HSA can be calculated by plotting 1/ (F0-F) vs. 1/L. 
Using linear regression program linear curve has been obtained as shown in figure  (4.10) 
 
Figure4. 10: plot for 1/ (F0-F) vs. L-1 
 
The equation of above linear curve was determined to be as described below: 
 
y=0.035826+0.040655x 
 
Intercept= 0.035826                                                        Slope=0.040655× 310− 
K=Intercept/Slope = 0.88122×103 
Which nearly agree with the value obtained earlier by UV technique. 
 
(1/ L) mM 
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4.3 FT-IR Spectroscopy 
 
FT-IR spectroscopy is a powerful technique for the study of hydrogen bonding; it has a 
wide spread application of qualitative and quantitative analyses in Chemistry, 
Biochemistry, Biology, Medicinal Chemistry and Environmental Science, it’s 
singlemostimportantusefortheidentiﬁcationoforganiccompounds,drugsandpollutants.Now,F
TIRspectroscopyisanestablishedmethodforthestructuralcharacterizationofproteins,DNAand
RNA.FTIRspectroscopywithitssecondaryderivativeswasused to determine protein 
conformation. (Zhou et al., 2009 , MM et al., 2014) 
IR spectral data including secondary structure of proteins are usually interpreted in terms 
of the vibrations of a structural repeat unit. These repeat units give rise to nine 
characteristic IR absorption bands, namely, amide A, B, and I−VII. which is a result of 
vibration of the groups around the peptide bond of proteins.(Kong et al., 2007 )                                     
 
 Amide I band ranging from 1700−1600 1−cm is the  most sensitive spectral region to the 
protein secondary structural components, this band is due to C=O stretch vibrations of the 
peptide linkages (approximately 80%) , Amide II band which is much less protein 
conformational sensitivity than its amide I ,  derives mainly from in-plane NH bending 
(40−60% of the potential energy) and from the C-N stretching vibration (18−40%) and it's 
in the range of (1600-1480) 1−cm  , while amide III band ranging from( 1330 to 1220 1−cm
)is due to the C-N stretching mode coupled to the in-plane N - H bending mode .(Jackson 
et al., 1991 )                                                              
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The second derivative of the absorption spectruem of free HSA is shown in figure (4.11B) 
and figure (4.12B) ,where the spectra is dominated  by absorbance bands of amide I and 
amide II at peak positions 1657 1−cm  and 1549 1−cm  for procaine's sample run ,and 1655
1−cm 1540 1−cm  for dopamine's sample run .  
Figure (4.11A), shows the spectrum of procaine HSA complexes with different 
concentration of Pro, and figure (4.12 A), shows the spectrum of Dopamine-HSA 
complexes with different concentration of dopamine. from that figure we can't  assume that 
the relation between the concentrations of two drugs are  proportional or inversely 
proportional to the intensity of the protein , since in this work the thickness of  the samples 
are not the same , we try to make it homogenous as possible as we can but the surrounding 
environment affect and prevent that purpose, from analysis process using Fourier self-
deconvolution ,second derivative ,peak positions and others we can study the change of the 
secondary structure of proteins after we added the drugs and see  its effect .   
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A         
 
B 
 
Figure4. 11:( B) The spectra of HSA free second derivative And (A) (a, b, c, d, e, f) 
procaine-HSA complex with concentration of (free HSA,0.15mM ,0.3mM,0.6mM,0.7 
mM,0.9 mM). 
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Figure4. 12:( B the lower one ) The spectra of HSA free second derivative And (A the 
upperr one ) (a, b, c, d, e, f) Dopamine-HSA complex. 
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Using Fourier self deconvolution and spectrum suptraction  paeak postions for both HSA-
Pro and HSA-DA have been displayed , the results show that there are some noticble 
change in the peak postions as shwon in figures (4.13 , 4.14 , 4.15 ,4.16).But in general the 
change are small and most of them were shift. 
 
 
 
Wavenumber 1−cm 
Figure4. 13: FT-IR spectra (top two curves, a and b) and differences spectra of HSA and its 
complexes with procaine (c, d, e, f, g) with concentration of (0.6Mm ,0.3Mm ,0.9Mm, 
0.7Mm ,0.15Mm) . 
 
 
 
 
  
77 
 
  
 
 
Figure4. 14: Top Part shows HSA spectra (B) and HSA-procaine 0.6mM (A) 
Bottom part shows the difference Spectra between (HSA-procaine complex) – (free HSA). 
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For (Dopamine-HSA) interaction the results are shown in figure (4.15) and (4.16) for FT-
IR spectra (top two curves) and difference spectra of HSA and its complexes with different 
dopamine concentrations and figure (4.16) for FSD spectra subtraction in amide I and 
amide II regions.  
 
 
Figure4. 15: FT-IR spectra (top two curves, a and b) and differences spectra of HSA and its 
complexes with DA (c, d, e, f, g) with concentration of (0.4Mm ,0.3mM, 0.7Mm,0.6Mm 
,0.5Mm). 
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 Figure4. 16: Upper Box: FSD spectra subtraction {(A) free HSA – (B) HAS- Dopamine 
0.7mM), Lower Box: the result of the subtraction. 
 
 
 
 
 
B
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Appearance of new feature band at 1603 1−cm  for procaine HSA complexes, Strong 
negative one in amide I band, and negative feature in amide II bands for both (Pro and DA 
–HSA) complexes attributed that there are change in intensity of amide I and II bands 
which is a results of change of the secondary structure of protein after combination with 
drugs which due to interaction (H-Bonding) of the procaine or Dopamine with protein 
C=O and C-N groups. (Tajmir et al., 2007 ) 
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Using Byler and Susi procedure, determination of the secondary structure of protein and its 
procaine or dopamine complexes was carried out (Byler et al., 1986 ), in this work, 
quantitative analysis of the protein secondary structure in a free case and after the 
interaction with two drugs determined from the shape of three amides I, II, and III. 
Many analysis procedures such as Fourier self-deconvolution, second derivative and 
integration one used to increase the spectral resolution to determine the parameters of each 
bands, such peak positions and area of each components of bands. 
The components bands of amide I,II, and III regions were assigned to a secondary structure 
according to the frequency of its maximum a raised after Fourier self-deconvolution have 
been applied for six times  .In our work  for amide I band ranging from 1600 1−cm - 1700 
1−cm assigned as follows: Both of 1606-1620 1−cm  and(1620 – 1633) 1−cm represented to β-
sheets  ,(1633 to 1647) 1−cm  to  random coil,1649 - 1670 1−cm  to α-helix,(1672-1686) 1−cm  
to turn structure , 1687-1700 1−cm  to β-antiparallel . 
For amide II region ranging from 1487-1600 1−cm , the absorption band assigned in the 
following order: Both of (1487-1506) 1−cm and (1506-1523) 1−cm  to β-sheet ,(1523-1539)  
to random coil ,(1541-1558) 1−cm  to α-helix , (1560-1577) 1−cm to turn structure ,and (1577-
1594) 1−cm  to β-antiparallel . 
 
For amide III ranging from 1220-1330 1−cm have been assigned as follows: 1220-1256
1−cm to β-sheet, 1259-1287 1−cm  to random coil, 1288-1302 1−cm to turn structure, and 
1302-1331 1−cm to α-helix.  
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Most investigations have concentrated on amid I band since it’s the most sensitive one for 
the secondary structure change, also many studies have been reported that amide II and III 
one has high information contents and can be used to study the secondary structure of 
protein. (Tajmir-Riahi et al., 2009 )                           
In our work the percentage of each secondary structure of HSA were calculated by 
normalization idea, which is integrated areas of the components bands in amide I, II, and 
III. Then assumed and divide by total area to get the portion of each components as 
described in table (4.9) and (4.10) for both HSA-Pro interaction and HSA-DA one 
respectively. 
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For Procaine: 
Amide I: 
The area for each component of amide I was determined using OPUS software program 
after 6 deconvolution as described in table (4.9) and figure (4.17) then we ssumed and 
divided by total area to get the portion of each component in that amide as shown in table 
(4.9). 
 
 
Figure4. 17: Deconvolution curve for determining bands and secondary structure for amide 
I 
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Table4. 3: Area for absorption bands for Procaine-HSA at different concentrations for 
amide I. 
 
Bands 
 
Range 
(cm-1) 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
Amide I 1700-1600 
 
0.0 
 
0.15mM 
 
0.3mM 
 
0.6mM 
 
0.7mM 
 
0.9mM 
 
β-sheets 
 
 
1606-1620 10.83 5.94 --- ---- --- ---- 
β-sheets 
 
1620-1633 21.58 23.85 24.9 38.75 55.68 50.23 
Random coil 
 
 
1633 -
1647 
34.80 26.41 29.98 37.09 34.26 28.38 
α-helix 1649 -
1670 
 
 
200.50 118.03 141.242 199.20 83.30 136.00 
Turn Structure 1672-1686 
 
 
77.45 55.25 71.99 79.46 70.29 63.55 
β-sheets 1687.-
1700 
 
 
85.3970 62.59 85.25  79.57 88.18 75.86 
 
 
Finding total area for each concentration to get: 
Total 428.55 292 353.36 435.079 331.70 354.00 
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Dividing each area for each concentration over the total area for that concentration   the 
proportion of the polypeptide chain in that conformation will be described as shown in 
table (4.9) in amide I section and figure (4.17). 
 
For Amide II: 
We used the same procedure that has been described in amide I. 
-
 
Figure4. 18: Deconvolution curve for determining bands and secondary structure for amide 
II. 
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Table4. 4: Area absorption of bands for Procaine-HSA at different concentrations for 
amide II 
Bands 
 
Range 
(cm-1) 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
Amide II 16001480 
 
0.0 
 
0.15mM 
 
0.3mM 
 
0.6mM 
 
0.7mM 
 
0.9mM 
 
β-sheets 
 
 
1487-1506 81.44 64.17 84.10 80.44 83.13 73.64 
β-sheets 
 
1506-1523 92.71 69.25 84.10 86.40 65.33 71.23 
Random 
coil 
 
1523 -
1539 
73.47 84.00 71.00 61.80 58.74 49.36 
α-helix 
 
1541-1558 155.17 136.30 151.54 155.82 124.43 132.5 
Turn 
Structure 
1560-1577 
 
 
126.00 101.91 124.49 128.91 126.21 118.49 
β-sheets 1577-1594 
 
 
139.57 87.18 137.00 116.26 156.79 106.85 
 
Finding total area for each concentration to get: 
 
Total  668.36 542.81 652.23 629.63 614.63 552.07 
 
Dividing each area for each concentration over the total area for that concentration the 
proportion of the polypeptide chain in that conformationshown as described in table (4.9) 
in amide II section and figure (4.18). 
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For Amide III: 
We used the same procedure to determine the portion of each component in amide III.The 
result is described in figure (4.19) and table (4.5). 
 
 
 
Figure4. 19: Deconvolution curve for determining range of the bands for secondary 
structure for amide III. 
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Table 4. 5: Area absorption bands for Procaine-HSA at different concentrations for amide 
III. 
 
Bands 
 
Range 
(cm-1) 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
Amide III 1320-
1220 
 
0.0 
 
0.15mM 
 
0.3mM 
 
0.6mM 
 
0.7mM 
 
0.9Mm 
 
β-sheets 
 
 
1222-
1556 
13.5 7.83 14.98 16.03 19.54 16.18 
Random 
coil 
 
1259-
1287 
3.88 4.04 10.62 19.2 27.8 25.07 
Turn 
Structure 
1288 -
1302 
1.41 1.04 1.57 2.33 2.84 2.82 
α-helix 
 
1302-1320 
 
 
7.62 
 
6.00 
 
8.19 10.06 
 
14.27 
 
11.58 
 
Finding total area for each concentration to get: 
 
Total  26.41 18.91 35.36 47.62 64.45 55.65 
 
Dividing each area for each concentration over the total area for that concentration got us 
the proportion of the polypeptide chain in that conformation. As described in table (4.9) in 
amide I section and figure (4.19). 
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For Dopamine: 
Amide I: 
 
 
 
Figure4. 20: Deconvolution curve for determining range of the bands for secondary 
structure for amide I. 
 
Table4. 6: Area absorption bands for DA-HSA at different concentrations for amide I. 
 
Bands 
 
Range (cm-1)  
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
Amide I 1700-1600 
 
0.0 
 
0.3mM 
 
0.4mM 
 
0.5mM 
 
0.6mM 
 
0.7mM 
 
β-sheets 
 
 
1614-1628 3.46096 3.47132 2.66451 1.94662 1.79462 1.61238 
Random 
coil 
 
 
1628-1643 15.3878 7.62809 11.2364 4.62827 14.8481 12.4106 
α-helix 1645 -1672 83.569 39.8713 64.6534 31.8005 93.1328 78.6391 
Turn 
Structure 
1674-1687 
 
 
15.9181 10.6252 13.4625 9.31549 16.649 12.8315 
β-sheets 1689-1700 
 
 
8.4323 9.77286 8.73578 9.95985 10.7573 6.31018 
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Finding total area for each concentration to get:  
 
Total  126.76 71.366 100.74 57.64 137.2 111.8 
 
Dividing each area for each concentration over the total area for that concentration got us 
the proportion of the polypeptide chain in that conformation. As described in table (4.10) 
in amide I section and figure (4.20). 
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For amide II: 
 
Figure4. 21: Deconvolution curve for determining range of the bands for secondary 
structure for amide II. 
  
Table4. 7: Area absorption bands for DA-HSA at different concentrations for amideII. 
Bands Range 
(𝑐𝑐𝑐𝑐−1)  
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
Amide II 1600-1480 
 
 
0.0mM 0.3mM 0.4mM 0.5mM 0.6mM 0.7Mm 
β-Sheet 1484-1500 
 
 
25.68 
 
15.238 
 
18.7358 
 
16.4326 
 
30.27 
 
22.4963 
 
Random 
Coil 
1502-1531 
 
91.57 
 
50.587 
 
61.6657 
 
32.593 
 
69.6393 
 
53.8371 
 
α-helix 1533 -1564 
 
 
81.75 52.730 117.869 67.1613 133.656 103.323 
Turn 
Structure 
 
1564 -1585  
 
 
70.35 
 
51.366  
 
65.9504 
 
 
47.1461 
 
74.1041 
 
53.878 
 
β-Sheet 
 
1585-1600  
 
103.8 
 
92.089 
 
101.968 
 
94.862 
 
106.062 
 
73.1984 
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We found total area for each concentration to get:  
 
Total  373.18 262.008 366.189 258.19 413.7 306.73 
 
Dividing each area for each concentration over the total area for that concentration got us 
the proportion of the polypeptide chain in that conformation. As described in table (4.10) 
in amide I section and figure (4.21). 
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For amide III: 
 
- 
Figure4. 22Figure : Deconvolution curve to determining range of the bands for secondary 
structure of DA-HSA interaction for amide III. 
 
Table4. 8: Area absorption bands for +DA-HSA at different concentrations for amide III 
 
 
Bands 
 
 
Range cm-1 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
 
[Area] 
Amide III 1320-1220 
 
 
0.0 
 
0.3mM 
 
0.4mM 
 
0.5mM 
 
0.6mM 
 
0.7mM 
 
β-sheets 
 
 
1222-1255 13.49 
 
12.298 
 
12.95 
 
11.32 
 
     16.00 
 
12.83 
 
Random 
coil 
 
1257-1281 5.14  
 
6.00 
 
7.00 
 
7.00 
 
      7.00 9.00 
 
Turn 
Structure  
1281 -1302 4.3 
 
6.94 
 
8.36 
 
10.7 
 
8.79 
 
11.74 
 
α-helix 
 
1302-1317 
 
5.99 
 
8.76 
 
7.8 
 
8.69 
 
7.67 
 
7.77 
 
Finding total area for each concentration:  
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 Total  28.92 33.9 36.11 37.71 40.46 41.34 
 
Dividing each area for each concentration over the total area for that concentration got us 
the proportion of the polypeptide chain in that conformation. As described in table (4.10) 
in amide III section and figure (4.22). 
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The secondary structure determination for the free HSA and its procaine or dopamine 
complexes, are given in (Table (4.9), and table (4.10).  
Table (4.9) and table (4.10) show the content of each secondary structure of HSA before 
and after the interaction with procaine and dopamine at different concentration, 
respectively. For HSA –procaine complex it's seen that α-helix percentage decrease with 
the increase of procaine concentration in the calculations, and this trend is consistent in the 
three amide regions. 
For procaine-HSA interaction: in amide I region HSA free consists of (20%) anti parallel 
β-sheet, (3%) and (5%) parallelβ-sheet, (8%) random coil, (46%) α-helical structure, and 
(18%) turn structure. After interaction of protein with procaine drug, α-helical structure 
reduces from (46%) to (39%), anti-parallel β-sheet structure increased from (20%) to 
(26%), while turn structure and random coil increase from (18%) to (21%) and (8%) to 
(10%) respectively. 
 
For amide II region, HSA free consists of (12%) and (14%) parallel-β-sheet, (21%) 
antiparallel-β-sheet, (11%) random coil, (23%) α-helical structure, and (19%) turn 
structure. After interaction with procaine drug, α-helical structure increase then return back 
to reduce from (23%) to (20%), parallel-β-sheet increase for some concentration and return 
back to decrease from (14%) to (13%), turn structure increase from (19%) to (21%), and 
random coil decrease from (11 %) to (9%).                                                                         
In amide III region HSA free consists of (51%) β-sheet structure, (15%) random coil, 
(29%) α-helix and (5%) turn structure. After interaction with procaine drug, β-sheet 
decrease from (51%) to (29%), α-helical structure reduces from (29%) to (21%), while 
random coil increases from (15%) to (45%), and turn structure stay (4%) for all samples.                                                                                  
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Table4. 9: Relative intensity of absorption bands for Procaine-HSA at different concen 
Bands Range (cm-
1) 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Amide I 1700-1600 0.0 0.15 mM 0.3mM 0.6mM 0.7mM 0.9mM 
        
β-sheets 1606-1620 3 5 --- --- --- --- 
β-sheets 1620-1633 5 7 7 9 17 14 
Random 1633-1647 8 8 9 9 10 8 
α-helix 1649-1670 46 40 40 46 25 39 
Turns 1672-1686 18 19 20 18 21 18 
β-sheets 1687-1700 20 21 24 18 26 21 
        
Amide II 1600-1480       
        
β-sheets 1487 1506 12 12 13 13 14 14 
β-sheets 1506-1523 14 13 13 14 11 13 
Random 1523- 1539 11 15 11 10 10 9 
α-helix 1541-1558 23 25 23 25 20 24 
Turns 1560-1577 19 19 19 20 21 21 
β-sheets 1577-1594 21 16 21 18 24 19 
        
Amide III 1320-1220       
        
β-sheets 1222-1256 51 41 42 34 30 29 
Random 1259-1287 15 21 30 40 43 45 
Turns 1288--1302 5 6 5 5 5 5 
α-helix 1302-1319 29 32 23 21 22 21 
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For dopamine-HSA interaction: in amide I region HSA free consists of (3%) parallel β-
sheet, (7%) antiparallel β-sheet, (12%) random, (65%) α-helical structure, (13%) turn 
structure. After dopamine-HSA interaction, see table (4.16), α helical structure increase 
from (65%) to (70%), parallel β-sheet decrease from (3%) to (1%), antiparallel β-sheet 
increase to (17%), both turn structure and random coil decrease from (13%) and (12%) to 
(11%) respectively. 
For amide II region HSA free consists of (7%)parallel β-sheet ,(27%) antiparallelβ-sheet 
(22%) α helical structure , (25%) random coil ,and (19%) turn structure .After dopamine –
HSA complexes , see table (4.16) , α helical structure increase from (22%) to (34%) 
,parallel β-sheet decrease to (6%) ,antiparallel β-sheet increase from (27%) to (37%) then 
return to decrease to (23%) , random coil decrease from (25%) to (19%) , and turn 
structure reduce from (19%) to (18%).  
In amide III HSA free consists of (47%) β-sheet, (20%) α-helical structure, (18%) random 
coil, and (15%) turn structure. After interaction with dopamine β-sheet decrease from 
(40%) to (30%), α helical structure increase from (20%) to (23%), random coil increases 
from (18%) to (20%) also turn structure increase from (15%) to (29%). 
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Table4. 10: Relative intensity of absorption bands for DA-HSA at different concen. 
 
 
 
 
 
Bands Range (cm-1) Intensity 
% 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Intensity 
% 
Amide I 1700-1600 0.0 0.3 mM 0.4mM 0.5mM 0.6mM 0.7mM 
        
β-sheets 1614-1628 3 5 3 3 1 1 
Random 1628-1643 12 11 11 9 11 11 
α-helix 1645-1672 65 56 65 55 68 70 
Turns 1674-1687 13 14 13 16 12 11 
β-sheets 1689-1700 7 14 8 17 8 7 
        
Amide II 1600-1480       
        
β-sheets 1484- 1500 7 6 5 6 6 6 
Random 1502-1531 25 19 17 13 18 19 
α-helix 1533- 1564 22 20 32 26 32 34 
Turns 1564-1585 19 20 18 18 18 18 
β-sheets 1585-1600 27 35 28 37 26 23 
        
Amide III 1320-1220       
        
β-sheets 1222-1255 47 36 36 30 39 30 
Random 1257-1281 18 18 19 19 20 20 
Turns 1281--1302 15 20 23 28 20 29 
α-helix 1302-1317 20 26 22 23 21 21 
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The decrease of a-helix percentage with the increase of procaine and increase of it with 
increasing of Dopamine concentrations is evident in the calculations and this trend is 
nearly consistent in three Amide regions. However, β-sheet relative percentage increased 
with increasing procaine and decrease with increasing of dopamine concentrations. 
 
The reduction of a-helix intensity percentage in favor of the increase of β-sheets and turn 
structure are believed to be due to the unfolding of the protein in the presence of procaine. 
Increase of a-helix intensity percentage in favor of the decrease of β-sheets are believed to 
be due to the folding of the protein in the presence of Dopamine as a result of the 
formation of H-bonding between HSA and the two drugs at C=O and C-N groups.  newly 
H-bonding result due to a flow of electrons from the C=O to the C-N bond which decreases 
the intensity of the original vibrations.(Tajmair et al., 2007 , Darwish et al ., 2010) 
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Chapter Five: Conclusions and future work 
 
The interaction between Procaine and Dopamine with albumin is of great interest from 
both the endocrinological and pharmaceutical point of view. In our work the interaction of 
procaine and Dopamine with HSA protein was investigated by means of UV-VIS 
spectrophotometer, Fluorescence spectrophotometer, andFT-IR spectroscopy. 
The experimental results indicate a low binding affinity between Procaine and Dopamine 
with HSA protein. From analysis of the UV spectrum, the binding constants for Procaine-
HAS and Dopamine-HSA are (1.00115599×103M-1, 0.849044×103M-1), respectively. The 
analysis of the Fluorcence spectrum yield binding constants for Procaine-HAS and 
Dopamine-HAS interaction, that have been measured to be (1.13818×103M-1, 
0.88122×103M-1), respectively. The binding constant obtained by different methods has 
very close values. In addition, the values of Stern-Volmer quenching rate constants for 
both Procaine and Dopamine were measured to be (0.566×109 Lmol-1s-1, 1.04665×109 
Lmol-1s-1 ), respectively. As a result, it was found that the decrease in Fluorcence intensity 
can be considered as the result of contribution of static and dynamic quenching, which is 
indicative of a complex formation between the protein with the procaine and Dopamine 
drugs. 
Analysis of FT-IR spectrum indicated that the increasing the concentration of Procaine or 
Dopamine lead the unfolding of protein, change the percentage of alpha helical structure 
and Beta sheet .Beside that it can be inferred that the binding forces which are involved in 
the binding processes includes hydrophobic interactions .The newly formed H-bonding  
results in the C-N bond assuming partial double bond character due to a flow of electrons 
from the OC = to C-N bond which decrease the intensity of the original vibrations. 
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 These experimental results may be useful for drug design, and provides some important 
information for clinical study of drugs, since the binding between them and HAS protein is 
weak as described in results its suggest to carry these drugs over heterogeneous compound. 
And since body temperature changes during inflammatory processes ,therefore, this 
research need further studies such as thermodynamic (parameters (enthalpy, free energy, 
entropy)at different temperature to investigate the changes in the binding characteristics of 
procaine and Dopamine with HSA.  
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ﺗﺄﺛﯿﺮات ﺗﻔﺎﻋﻞ اﻟﻤﺨﺪر اﻟﻤﻮﺿﻌﻲ )ﺑﺮوﻛﺎﯾﯿﻦ( واﻟﻨﺎﻗﻞ اﻟﻌﺼﺒﻲ )دوﺑﺎﻣﯿﻦ( ﻣﻊ ﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي ﻣﻦ 
 ﺧﻼل اﻟﺘﺤﻠﯿﻞ اﻟﻄﯿﻔﻲ
 
 إﻋﺪاد: راﻧﯿﺔ ﻋﺒﺪ اﻟﺠﻠﯿﻞ ﺳﻠﯿﻤﺎن ﻓﻘﯿﺎت
 
  ﻣﻮﺳﻰ اﺑﻮ طﯿﺮ د. :ﺷﺮافإ
: اﻟﻤﻠﺨﺺ
ﺗﻮزﯾﻊ وﻋﻤﻠﯿﺎت اﻷﯾﺾ ﻟﻜﺜﯿﺮ ﻣﻦ اﻟﻌﻨﺎﺻﺮ اﻟﺒﯿﻮﻟﻮﺟﯿﺔ ﻓﻲ اﻟﺠﺴﻢ ﺳﻮاء ﻛﺎﻧﺖ أﻣﺼﺎل أو ﻣﻨﺘﺠﺎت طﺒﯿﻌﯿﺔ،ﻣﺮﺗﺒﻄﺔ الإن 
دراﺳﺔ ارﺗﺒﺎط ﻣﺜﻞ ھﺬه اﻟﺠﺰﯾﺌﺎت ﻣﻊ ﺑﺮوﺗﯿﻦ    أن،اذASH( ﺑﻘﺪرة ھﺬه اﻟﻌﻨﺎﺻﺮ ﻋﻠﻰ اﻹرﺗﺒﺎط ﻣﻊ ﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي)
ة أﺳﺎﺳﯿﺔ .دراﺳﺎت واﺳﻌﺔ اﻟﻨﻄﺎق ﻋﻠﻰ ﺟﻮاﻧﺐ ﻣﺨﺘﻠﻔﺔ ﻟﺘﻔﺎﻋﻞ ﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي ﻣﻊ ياﻟﺪم اﻟﺒﺸﺮي ﺣﺘﻤﻲ وﻟﮫ أھﻢ
اﻷﻣﺼﺎل ﻻ ﺗﺰال ﻓﻲ اﻟﺘﻘﺪم ﻷھﻤﯿﺔ ھﺬه اﻟﺪراﺳﺎت ﻓﻲ اﻟﻌﻤﻠﯿﺎت اﻟﻌﻼﺟﯿﺔ. 
 
( واﻟﻨﺎﻗﻞ اﻟﻌﺼﺒﻲ ﻓﻲ orPﻓﻲ ھﺬه اﻟﺪراﺳﺔ ﺗﻢ دراﺳﺔ ﺗﺄﺛﯿﺮ اﻟﻤﺨﺪر اﻟﻤﻮﺿﻮﻋﻲ اﻟﺬي ﯾﺴﺘﺨﺪم ﺑﺎﻟﻌﻤﻠﯿﺎت اﻟﺠﺮاﺣﯿﺔ )
 ﻋﻨﺪ درﺟﺔ   nimublA( mureS namuHﻣﻊ ﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي ) )AD(اﻟﺠﮭﺎز اﻟﻌﺼﺒﻲ اﻟﻤﺮﻛﺰي ﻟﻠﺜﺪﯾﺎت 
 وﺟﮭﺎز retemotohportceps( SIV-VUاﻟﺤﻤﻮﺿﺔ اﻟﻔﺴﯿﻮﻟﻮﺟﯿﺔ ،ﺑﺎﺳﺘﺨﺪام ﺟﮭﺎز ﻣﻄﯿﺎف اﻷﺷﻌﺔ ﻓﻮق اﻟﺒﻨﻔﺴﺠﯿﺔ )
(. RI-TF وﺟﮭﺎز ﻣﻄﯿﺎف ﺗﺤﻮﯾﻞ ﻓﻮرﯾﯿﺮ ﻟﻸﺷﻌﺔ ﺗﺤﺖ اﻟﺤﻤﺮاء )  retemotohportcepS ecnecroulF( )اﻹﺷﻌﺎع
 
أظﮭﺮت اﻟﻨﺘﺎﺋﺞ أن ﺷﺪة إﻣﺘﺼﺎص اﻷﺷﻌﺔ اﻟﻔﻮق ﺑﻨﻔﺴﺠﯿﺔ ﻟﺒﺮوﺗﯿﻦ اﻟﺪم ﺗﺰداد ﺑﺰﯾﺎدة ﻧﺴﺐ اﻟﺒﺮوﻛﯿﻦ وﻛﺬﻟﻚ اﻟﺪوﺑﺎﻣﯿﻦ ﻣﻊ 
ﻟﻠﺒﺮوﻛﯿﻦ   301×5800.1( وﻣﻦ طﯿﻒ اﻷﺷﻌﺔ اﻟﻔﻮق ﺑﻨﻔﺴﺠﯿﺔ ﺗﻢ ﺣﺴﺎب ﺛﺎﺑﺖ اﻟﺘﺮاﺑﻂ واﻟﻘﯿﻢ ھﻲ ) .ﺛﺒﺎت ﺗﺮﻛﯿﺰ اﻟﺒﺮوﺗﯿﻦ
( ﻟﻠﺪوﺑﺎﻣﯿﻦ. 440948.0  301×و )
 
وﻣﻦ ﺧﻼل ﺗﺤﻠﯿﻞ اﻹﺷﻌﺎع اﻟﻤﻨﺒﻌﺚ،أﺳﺘﻨﺘﺞ أن اﻟﺒﺮوﻛﯿﯿﻦ واﻟﺪوﺑﺎﻣﯿﻦ ﻟﮭﻤﺎ اﻟﻘﺪرة ﻋﻠﻰ ﺧﻔﺾ ﺷﺪة اﻹﺷﻌﺎع اﻟﻤﻨﺒﻌﺚ ذاﺗﯿﺎ 
. gnihcneuq cimanyD dna citatS(ﻣﻦ ﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي ﻣﻦ ﺧﻼل ﺗﺪاﺧﻞ ﻣﺎ ﺑﯿﻦ اﻟﯿﺔ )
 
 411
 
  301×22188.0( )ﻟﻠﺒﺮوﻛﯿﻦ و  301×8811.1(اﯾﻀﺎ ﻣﻦ ﺧﻼل طﯿﻒ اﻟﻐﺸﻌﺎع اﻟﻤﻨﺒﻌﺚ ﺗﻢ إﯾﺠﺎد ﺛﺎﺑﺖ اﻟﺘﺮاﺑﻂ وھﻮ )
ﻟﻠﺪوﺑﺎﻣﯿﻦ ﻣﻊ ﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي،ﻣﻦ اﻟﻮاﺿﺢ أن ھﺬه اﻟﻘﯿﻢ ﺗﺘﻨﺎﺳﺐ ﻣﻊ اﻟﻘﯿﻢ اﻟﺘﻲ ﺗﻢ اﻟﺤﺼﻮل ﻋﻠﯿﮭﺎ ﻟﺜﺎﺑﺖ اﻟﺘﺮاﺑﻂ ﻣﻦ 
ﺟﮭﺎز ﻣﻄﯿﺎف اﻷﺷﻌﺔ ﻓﻮق اﻟﺒﻨﻔﺴﺠﯿﺔ. 
 
( و noitulovnoced-fleS reiruoFﺑﺎﺳﺘﺨﺪام ﺟﮭﺎز ﻣﻄﯿﺎف ﺗﺤﻮﯾﻞ ﻓﻮرﯾﯿﺮ ﻟﻸﺷﻌﺔ ﺗﺤﺖ اﻟﺤﻤﺮاء ﻣﻊ ﺗﻄﺒﯿﻖ ﺗﻘﻨﯿﺔ )
ﺣﺪ وأﻣﯿﺪ اﺛﻨﺎن وأﻣﯿﺪ ﺛﻼﺛﺔ ﻓﻲ ا( ﺗﻢ ﺗﺤﻠﯿﻞ ﻣﻨﺎطﻖ اﻣﯿﺪ وgnikcip kaeP( ﺑﺎﻹﺿﺎﻓﺔ اﻟﻰ ﺗﻘﻨﯿﺔ )evitavireD dnoceS)
( واﻟﯿﺔ ارﺗﺒﺎط اﻟﺒﺮوﻛﯿﻦ واﻟﺪوﺑﺎﻣﯿﻦ ﻣﻊ erutcurtS yradnoceSﺑﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي ﻟﺘﺤﺪﯾﺪ ﺑﻨﯿﺔ اﻟﺒﺮوﺗﯿﻦ اﻟﺜﺎﻧﻮﯾﺔ )
 ﺑﺮوﺗﯿﻦ اﻟﺪم ﻓﺈن ﺷﺪة ﺣﺰم اﻹﻣﺘﺼﺎص ﺗﻘﻞ وھﺬا ىﺑﺮوﺗﯿﻦ اﻟﺪم،ﻟﻘﺪ ﻟﻮﺣﻆ أﻧﮫ ﻣﻊ زﯾﺎدة ﺗﺮاﻛﯿﺰ اﻟﺒﺮوﻛﯿﯿﻦ أو اﻟﺪوﺑﺎﻣﯿﻦ إل
ﯾﺪل ﻋﻠﻰ ﺣﺪوث اﻟﺘﻔﺎﻋﻞ .اﯾﻀﺎ ﺟﻤﯿﻊ اﻟﻘﻤﻢ ﺗﻢ ﺗﺤﺪﯾﺪھﺎ ﻋﻨﺪ ﻋﺪة ﻧﺴﺐ ﻣﻦ اﻟﺒﺮوﻛﯿﯿﻦ أو اﻟﺪوﺑﺎﻣﯿﻦ ﺑﺎﻟﻤﻘﺎرﻧﺔ ﻣﻊ ﺑﺮوﺗﯿﻦ 
اﻟﺪم اﻟﺒﺸﺮي . 
 
إﺿﺎﻓﺔ إﻟﻰ ذﻟﻚ أظﮭﺮ اﻟﻄﯿﻒ اﻟﻤﻘﺎس ﺑﻮاﺳﻄﺔ ﺟﮭﺎز ﻣﻄﯿﺎف ﺗﺤﻮﯾﻞ ﻓﻮرﯾﯿﺮ ﻟﻼﺷﻌﺔ ﺗﺤﺖ اﻟﺤﻤﺮاء أن اﻟﺒﻨﯿﺔ اﻟﺜﺎﻧﻮﯾﺔ 
ﻟﺒﺮوﺗﯿﻦ اﻟﺪم اﻟﺒﺸﺮي،ﺗﻐﯿﺮت ﻧﺘﯿﺠﺔ إﺿﺎﻓﺔ ﻧﺴﺐ ﻣﻦ اﻟﺒﺮوﻛﯿﯿﻦ واﻟﺪوﺑﺎﻣﯿﻦ ، اﻟﺬي أظﮭﺮ ﺗﻐﯿﯿﺮ واﺿﺢ ﻋﻠﻰ ﻧﺴﺐ ﺷﺪة 
ھﺬا اﻟﺘﺒﺎﯾﻦ β( ,  -steehsل )   ﺑﺎﻟﻤﻘﺎرﻧﺔ ﻣﻊ ﻣﻊ ﺣﺰم اﻹﻣﺘﺼﺎص اﻟﻤﻤﺜﻠﺔ(-α xilehاﻹﻣﺘﺼﺎص اﻟﻤﻤﺜﻠﺔ  ل )
 ﻓﻲ اﻟﺠﺰﯾﺌﺎت اﻟﻤﻌﻘﺪة ، وھﻮ ﻣﺎ ﯾﻔﺴﺮ  gnidnoB-H(واﻹﺧﺘﻼف ﻓﻲ اﻟﺸﺪة ﯾﺮﺟﻊ اﻟﻰ ﺗﻜﻮﯾﻦ اﻟﺮواﺑﻂ اﻟﮭﯿﺪروﺟﯿﻨﯿﺔ )
 ﻟﺘﻜﻮﯾﻦ ھﺬه اﻟﺮواﺑﻂ . (βsteehS--α( و )xilehاﻟﻤﯿﻮل اﻟﺬاﺗﻲ ﻟﻜﻞ ﻣﻦ )
 
 511
 
